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ABSTRACT 
 
Palladium-Catalyzed Synthesis of Carbazole Derivatives and the Formal 
Total Syntheses of Several Naturally Occurring Carbazole Alkaloids 
 
Tricia L. Scott 
 
 
A mild and efficient route to substituted carbazolones has been developed.  This novel 
procedure consists of two consecutive palladium-catalyzed reactions, an intermolecular Stille 
coupling followed by an intramolecular reductive N-heteroannulation.  For example, 1,2-
dihydro-4(3H)-carbazolone was prepared in good isolated yield (74%) by the reductive 
cyclization of 2-(2-nitrophenyl)-2-cyclohexen-1-one using Pd(dba)2 (6 mol%), 1,3-
bis(diphenylphosphino)propane (6 mol%), 1,10-phenanthroline monohydrate (12 mol%), and 
carbon monoxide (90 psi) in DMF at 80 oC.  2-(2-Nitrophenyl)-2-cyclohexen-1-one was 
prepared via a Stille coupling of 2-iodo-2-cyclohexen-1-one and 2-(tri-n-butylstannyl)-1-
nitrobenzene.  Many functional groups and ring sizes were tolerated in these reactions. 
 This novel approach to carbazolones was successfully applied to the formal total 
syntheses of several naturally occurring carbazole alkaloids including murrayaquinone A, 
murrayafoline A, koenigine-quinone A, murrayanine, dimeric O-demethylmurrayafoline A, and 
(+)-aspidospermidine.  These new syntheses are generally more efficient and higher yielding 
compared to the previously reported syntheses of these natural products. 
 In addition, reductive cyclizations of 2-(2-nitrophenyl)-2-cycloalkenones using 10% Pd/C 
and 1 atm of hydrogen gas in methanol at ambient temperature yielded carbazole derivatives in 
excellent yields.  For example, reduction of 2-(2-nitrophenyl)-2-cyclohexen-1-one gave 1,2,3,4-
tetrahydrocarbazole in 95% yield.  Methyl-substitution on the cyclohexenone ring 
regioselectively produced methyl-substituted tetrahydrocarbazoles, however substitution on the 
benzene ring led to mixtures of carbazole products.   
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Part I 
 
Synthesis of Carbazolones via Palladium-Catalyzed  
N-Heteroannulations 
 
 
 
1.  Introduction 
Carbazole alkaloids have received considerable attention since their discovery in the 
1960’s and the realization of their pharmacological potential.1  They exhibit a wide range of 
biological properties ranging from antibiotic to antitumor activity.  Developing new synthetic 
methods toward the core carbazole structure in these alkaloids is of great interest to researchers. 
 
1.1.  Carbazolones 
Carbazolones are carbazole derivatives that are interesting synthetic targets.  Many 
carbazolones are biologically active.  The synthetic drug ondansetron2 shown in Figure 1 is a 
carbazolone that is a potent 5-HT3 receptor antagonist used to prevent severe nausea often caused 
by chemotherapy and radiation treatments in cancer patients. 
 
Figure 1 
N
O
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N
N
Me
Ondansetron
 
 
Carbazolones are also of interest as synthetic precursors to naturally occurring 
carbazoles.  A common method for preparing carbazolequinones involves the oxidation of 
   
 2 
carbazolones.  For example, carbazolone 1 was oxidized to the carbazole alkaloid 
murrayaquinone-A using 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) (Scheme 1).3 
 
Scheme 1 
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1 2 (45%)
 
 
A variety of methods have been utilized to obtain carbazolones.  One of the most 
common methods used is the Fischer indole synthesis.  1,2-Dihydrocarbazol-4(3H)-one (5) was 
synthesized by the Fischer reaction of phenylhydrazine and 1,3-cyclohexanedione (Scheme 2).4 
 
Scheme 2 
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Palladium-catalyzed Heck-type reactions have also been used to produce carbazolones.  
The intramolecular catalytic cyclization of bromo enaminones such as 6 produced carbazolones 
in variable yields (Scheme 3).5 
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Scheme 3 
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Carbazolones have also been synthesized by the arynic condensation of enaminones in 
the presence of  NaNH2-tBuONa according to Scheme 4.6 
 
Scheme 4 
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In the search for new analogs of carbazole alkaloids with modified pharmacological 
activity azacarbazoles have been studied.  One approach to azacarbazoles involves the 
photocyclization of N-(chloropyridinyl)enaminones (Scheme 5).7 
 
Scheme 5 
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Benzo[5,6]cyclohepta[b]indol-6-one derivatives have been prepared by the 
intramolecular cyclization of acids such as 13 using a large excess of polyphosphoric acid 
(Scheme 6).8  Derivatives of 14 are being studied for their antitumor potential. 
 
Scheme 6 
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1.2.  Reductive N-Heteroannulation Reactions 
 Recently, a new procedure for the synthesis of indoles was developed in our group.9  This 
new procedure involves the palladium-catalyzed reductive N-heteroannulation reaction of 2-
nitrostyrenes (Scheme 7).  Three reagents were found to be crucial in this reaction:  a palladium 
catalyst, a phosphine, and carbon monoxide.  This reaction has proved to be useful for the 
synthesis of a number of indole products including several mushroom metabolites (Figure 2).10 
 
Scheme 7 
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Pd(OAc)2, PPh3
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Figure 2 
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This type of reaction is not unknown in the literature.  There are other reports of 
reductive carbonylations of nitroarenes with unsaturated groups in the ortho position leading to 
indoles.  Watanabe et al11 published a related procedure using a catalytic amount of 
PdCl2(MeCN)2 in the presence of triphenylphosphine, excess tin dichloride, and 20 atm of 
carbon monoxide (Scheme 8).  Another very similar reaction was reported by Cenini et al12 using 
Pd(TMB)2/TMPhen (TMBH = 2,4,6-trimethylbenzoic acid; TMPhen = 3,4,7,8-tetramethyl-1,10-
phenanthroline) as the catalytic system (Scheme 9).  Many other kinds of heterocyclic 
compounds can be obtained from this type of reaction including amides, amines, oximes, ureas, 
carbamates, and isocyanates.13 
 
Scheme 8 
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Scheme 9 
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All these metal-catalyzed reductive cyclization reactions generally produce good yields 
of indoles.  However, compared to the method developed in our group most of these methods 
employ rather harsh conditions.  The reaction conditions developed in our group are much 
milder.   Our reactions proceed at a much lower pressure of carbon monoxide, lower 
temperature, and do not require the addition of a Lewis acid such as tin dichloride. 
 Due to the inherent similarity between indoles and carbazoles, we decided to apply this 
new method to the synthesis of carbazole derivatives.  The synthesis of several substituted 
carbazolones using this palladium-catalyzed reductive cyclization reaction is presented. 
 
2.  Results and Discussion 
 We envisioned that carbazolones could be prepared via the reductive cyclization of 2-(2-
nitrophenyl)-2-cyclohexenones as shown in Scheme 10.  First, we needed to develop a method to 
synthesize a variety of substituted 2-(2-nitrophenyl)-2-cycloalkenones in order to test the scope 
and limitations of our reductive cyclization. 
 
Scheme 10 
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We decided to make our cyclization precursors via a Stille coupling reaction between 
cycloalkenones and nitrobenzenes.  Johnson et al14 have reported the Stille couplings of 2-
iodocycloalkenones with aryl stannanes using 5 mol% PdCl2(PhCN)2, 10 mol% Ph3As, and 10 
mol% CuI in NMP (N-methylpyrrolidinone) to produce 2-phenyl-2-cyclohexenones in good 
yields.  We adapted these conditions to our Stille reactions with good results (Scheme 11).   
Table 1 shows the results of our Stille couplings to produce a variety of substituted 2-(2-
nitrophenyl)-2-cycloalkenones.  Some modifications of the reaction conditions were required for 
the synthesis of compounds 37 and 40.  Best yields of 37 were obtained when Ph3As was 
replaced with dppf  (1,1’-bis(diphenylphosphino)ferrocene).  The yield of 40 was improved 
slighty by degassing the reaction mixture.  Compound 38 was prepared via an alternative 
procedure using PdCl2(PPh3)2 in DMF.   
Most of the Stille couplings proceeded in good yields.  Slightly lower yields were 
obtained from aryl bromides as compared to aryl iodides.  The lower yields of 38 and 40 are 
probably due to steric factors.  In comparing entries 1 and 6 we see very little difference in yield 
resulting from reversing the polarity of substrates in the reaction.  The use of an aryl stannane 
and vinyl iodide or a vinyl stannane and an aryl iodide both give the Stille product in good yield. 
Products of the Stille reactions were easily discernable from starting materials by 1H 
NMR.  For example, the C-H proton in iodocyclohexenone 19 shows up as a triplet at 7.76 ppm, 
while the same proton in coupling product 32 is located upfield at 6.98 ppm. 
Some side-products complicating the purification of the desired compounds were 
identified in the Stille reactions (Figure 3).  In some cases the homocoupling product 42 or 43 
was present in significant amounts.  Butyl group transfer also occurred in the reaction of 30 
producing methyl 2-butyl-3-nitrobenzoate (44).  Homocoupling of stannanes is a common side 
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reaction in Stille couplings.15  Although the transfer of alkyl groups from the stannane is 
generally much slower than the transfer of aryl or vinyl groups, the transfer of alkyl groups is 
also sometimes observed.16 
 
Scheme 11 
O
I NO2
SnBu3
+
PdCl2(PhCN)2, Ph3As
CuI, NMP, 80 oC
O
NO2
76%
 
Table 1a 
O
I NO2
SnBu3 O
NO2
Entry Cycloalkenone Nitrobenzene Stille Product
O
I
O
NO2
O
I
O
I
O
Br
O
NO2
O
NO2
O
NO2
19
20
21
22
23
25 32 (76%)
33 (74%)
34 (65%)
35 (68%)
36 (46%)
1
2
3
4
5
"
"
"
"
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Table 1 continued 
O
SnBu3 NO2
NO2
NO2
NO2
NO2
NO2
O
NO2
O
NO2
O
NO2
O
NO2
O
NO2
O
NO2
Br
Br
MeO2C
OMe
MeO2C
Br
Entry Cycloalkenone Nitrobenzene Stille Product
24
I
I
26
27
28
29
30
32 (71%)
37 (67%)b
38 (31%)c
39 (62%)
40 (44%)d
41 (56%)31
Br
MeO
6
7
8
9
10
11
"
"
"
"
"
IBr
 
 a) General conditions:  1.2 eq. Sn reagent, 5 mol% PdCl2(PhCN)2, 10 mol% Ph3As, 10 mol% CuI, NMP, 80 
oC.  For more exact details see:  Experimental Section.  b) Ph3As was replaced with dppf.  c) Conditions used:  
PdCl2(PPh3)2, DMF, 110 oC.  d) Reaction mixture was degassed. 
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Figure 3  
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Two different organostannanes were prepared for the Stille reactions.  Aryl stannane 25 
was prepared from 1-iodo-2-nitrobenzene (26) according to Kosugi’s procedure17 (Scheme 12) 
using hexabutylditin, in situ formed Pd(PPh3)4, and toluene.  Vinyl stannane 24 was prepared 
according to Scheme 13.  The metal-halogen exchange reaction of 46 with t-BuLi, followed by 
addition of tributyltinchloride and deprotection of the ketone with acid produced the stannane 24 
in 83% yield. 
 
Scheme 12 
I
NO2
(Bu3Sn)2, Pd(dba)2
PPh3, Toluene, 80 oC
SnBu3
NO2
26 25 (80%)
 
 
Scheme 13 
O
1) Br2, Et3N, CHCl3
2) HOCH2CH2OH, CSA, Benzene
OO Br 1) t-BuLi, Ether
2) SnBu3Cl
3) H+
O
SnBu3
45 46 (89%) 24 (83%)
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 The literature procedure was followed for preparing 2-iodocycloalkenones 19 and 21, and 
this method was utilized for the preparation of the previously unknown compounds 20 and 22 
(Scheme 14).18  Most of the cycloalkenone starting materials were commercially available.  5-
Methyl-2-cyclohexen-1-one (47) was prepared according to literature procedure19 (Scheme 15), 
although in our hands this reaction failed to produce the reported yield of 78% for this 
compound. 
 
Scheme 14 
O
(   ) nR
O
R (   ) n
I2, CCl4, Pyridine
I
19
 (81%), R = H, n = 1
20
 (85%), R = CH3, n = 1
21
 (42%), R = H, n = 0
22
 (69%), R = H, n = 2
 
 
Scheme 15 
OEt
O O
H
O
+
t-BuOK, t-BuOH
O
47 (20%)
 
 
 Bromobenzocycloheptenone 52 was prepared from 1-benzosuberone (48) according to 
Scheme 16.  The silyl enol ether 49 was converted to benzocycloheptenone 50 by a palladium-
catalyzed dehydrosilylation reaction.20  Compound 52 was then prepared via a literature 
procedure consisting of a two step bromination-dehydrobromination sequence.21 
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Scheme 16 
O
1) LDA, THF
2) TMSCl, Et3N
OTMS
Pd(OAc)2, O2, DMSO
O
48 49 (95%) 50 (93%)
Br2, CaCO3, Ether
O
Br
Br
Acidic Alumina
Ether
O
Br
51 (97%) 52 (70%)
 
 
Nitrobenzenes 26 and 28 were commercially available.  Compounds 27 and 30 were 
previously synthesized in our laboratory according to literature procedures.9, 10  Compounds 29 
and 31 were prepared by the Sandmeyer type reactions of their corresponding anilines (Scheme 
17). 
 
Scheme 17 
NH2
NO2 1) H2SO4, H2O, NaNO2
2) KI, H2O, Cu I
NO2
NH2
NO2
Br
1) H2SO4, H2O, NaNO2
2) KI, H2O, Cu I
NO2
Br
53 29 (88%)
54 31 (61%)
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With the preparation of several substituted 2-(2-nitrophenyl)-2-cycloalkenones we now 
had sufficient substrates ready to test the scope of the reductive cyclization reaction.  Our first 
attempted N-heteroannulation of 32 using palladium diacetate (6 mol%), triphenylphosphine (24 
mol%), and carbon monoxide (4 atm) in acetonitrile at 70 oC surprisingly gave only starting 
material.  Since it is known that palladium phenanthroline complexes are particularly active 
catalysts for the reductive carbonylation of nitrobenzenes forming isocyanates,22 we chose to 
modify our cyclization conditions to those shown in Scheme 18.  The expected 1,2-dihydro-
4(3H)-carbazolone (5) was obtained in good isolated yield using Pd(dba)2 (6 mol%), dppp (1,3-
bis(diphenylphosphino)propane) (6 mol%), 1,10-phenanthroline monohydrate (12 mol%), and 
carbon monoxide (90 psi) in DMF at 80 oC. 
Next we tested these promising reaction conditions on the substrates shown in Table 1.  
Results of these reductive cyclizations are summarized in Table 2.  All reactions proceeded 
smoothly affording excellent yields of products.  Five-membered to seven-membered 
cycloalkenones all gave good results.  Substitution on the cycloalkenone ring was also well 
tolerated in the reaction.  The presence of electron donating or withdrawing groups at various 
positions on the aryl ring also presented no problems with the N-heteroannulation. 
  
Scheme 18 
O
NO2
Pd(dba)2, dppp
1,10-Phenanthroline monohydrate
CO (90 psi), DMF, 80 oC N
H
O
32 5 (74%)
 
 
   
 14 
Most of the reductive cyclizations were complete in 1-3 days.  However, substrate 41 
required an extended period of 8 days to go to completion.  The yield of the bromocarbazolone 
63 also was slightly lower than the other cyclizations.  4-Bromo substitution has previously been 
problematic in this type of reaction.  The attempted cyclization of the related substrate, 
bromonitrostyrene 64, performed previously in our laboratory yielded only starting material 
(Scheme 19).9 
 
Table 2a 
O
NO2
Stille Product
O
NO2
O
NO2
O
NO2
O
NO2
32
33
34
35
36
N
H
O
5 (74%)
N
H
O
55 (89%)
N
H
56 (86%)
N
H
57 (66%)
N
H
58 (86%)
O
O
O
Carbazolone
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Table 2 continued 
O
NO2
O
NO2
O
NO2
O
NO2
O
NO2
OMe
MeO2C
Br
37
38
39
40
41
Stille Product Carbazolone
N
H
O
N
H
O
N
H
O
N
H
O
N
H
O
OMe
MeO2C
Br
59 (89%)
60 (79%)
61 (75%)
62 (75%)
63 (52%)
 
 a) General conditions:  Pd(dba)2 (6 mol%), dppp (6 mol%), 1,10-Phenanthroline monohydrate (12 mol%), 
CO (90 psi), DMF, 80 oC.  For more exact details see:  Experimental Section. 
 
Scheme 19 
NO2
Br Pd(OAc)2, PPh3
CO (4 atm), MeCN
70 oC
N
H
64 65 (0%)
Br
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 The formation of 58 is of substantial synthetic interest.  Benzocycloheptaindole 
derivatives are being studied for their antitumor potential.8  This reaction could be useful for the 
preparation of such compounds. 
The cyclization reactions are typically monitored by thin layer chromatography.  Progress 
of the reactions can also be determined by 1H NMR.  Cyclization products are distinguishable 
from starting materials by certain NMR characteristics including the presence of a broad N-H 
peak between 8 and 11 ppm and the disappearance of the triplet C-H signal of the starting 
material.  For example, carbazolone 5 has a distinct N-H signal at 8.55 ppm and the C-H triplet 
at 6.98 of the starting material 32 has disappeared. 
 New synthetic analogs of carbazoles are currently being investigated for their modified 
biological activity.  For this reason we decided to apply our reductive cyclization reaction toward 
the synthesis of an azacarbazole (Scheme 20).  We constructed the cyclization precursor 67 via a 
Stille coupling reaction of 2-chloro-3-nitropyridine (66) and stannane 24.  The Stille product 67 
could not be isolated in any significant amount, although the crude NMR indicated that the 
reaction was working well.  We were convinced that the isolation problem was due to extensive 
decomposition upon purification by silica gel chromatography.  We were unable to isolated the 
product in any yield greater that 33% after column chromatography.  Therefore, we opted to 
carry on the crude Stille product to the cyclization reaction.  This proved to be a good decision 
providing the azacarbazole 68 in 54% yield over two steps. 
In a search for alternative substrates for the cyclization reaction we discovered an 
additional route to 1,2-dihydro-4(3H)-carbazolone (5).  2-(2-Nitrophenyl)-1,3-cyclohexanedione 
(70) and 3-methoxy-2-(2-nitrophenyl)-2-cyclohexenone (71), derived from 1,3-
cyclohexanedione23 (69), both gave the carbazolone product 5 in good yields, although reaction 
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times were much longer compared to the reductive cyclization of 32 even at elevated 
temperatures (Scheme 21). 
 
Scheme 20 
O
SnBu3
N
NO2
Cl
Pd(dba)2, Ph3As
CuI, NMP, 80 oC
+
O N
NO2
Pd(dba)2, dppp
1,10-Phenanthroline
CO (90 psi), DMF, 80 oC
N
H
NO
24 66 67
68 (54%, two steps)
 
 
Scheme 21 
O
O
+
NO2
I
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 At this time the mechanism for the reductive cyclization reaction remains unknown.  It is 
very unlikely that the reaction proceeds by initial reduction of the nitro group to an amine 
followed by an amino-	
-hydride elimination sequence as in the Hegedus indole 
synthesis.24  This type of reaction requires a palladium (II) catalyst which has to be regenerated 
by an added oxidant.  No oxidant is present in these cyclization reactions.  There are also 
mechanistic studies indicating that the formation of aniline is insignificant in the formation of 
indoles.25  Additional evidence against the role of aniline in the carbazolone reactions is that the 
direct reduction of the nitro group in 2-(2-nitrophenyl)-2-cyclohexenones by palladium-catalyzed 
hydrogenation does not produce carbazolones.  The results of this study are presented in part III.   
 Watanabe et al have proposed through some mechanistic studies that the reaction 
proceeds through the formation of an active transition metal nitrene intermediate followed by an 
insertion reaction.26, 11  Although no metal-bound nitrene intermediates have been isolated in the 
indole syntheses, the reaction of 2-nitrobiphenyl (72) using Ru3(CO)13 produced the ruthenium-
bound nitrene 73 (Scheme 22).27  The structure of 73 was determined by X-ray crystallography.  
When treated with carbon monoxide 73 gives carbazole as well as 2-aminobiphenyl.  This 
evidence supports the theory that a nitrene intermediate is involved in the synthesis of indoles. 
 
Scheme 22 
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One possible mechanism to a nitrenoid intermediate by a deoxygenative sequence is 
presented in Scheme 23.  Palladium addition to the nitro group followed by carbon monoxide 
insertion and elimination of carbon dioxide could give a palladium-nitroso intermediate.  
Another insertion by carbon monoxide and subsequent elimination of carbon dioxide gives the 
palladium-bound nitrene.  Insertion into the C-H bond of the cyclohexenone by the nitrene can 
follow to give the carbazolone product. 
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3.  Conclusions 
 We have successfully developed a mild and efficient method of preparing functionalized 
carbazolones.  This novel route consists of two sequential palladium-catalyzed reactions, an 
intermolecular Stille coupling followed by a reductive N-heterocyclization.  Many functional 
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groups and ring sizes are well tolerated in these reactions.  This novel procedure has been 
applied to the synthesis of naturally occurring carbazole alkaloids presented in the next section.  
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Part II 
Formal Total Syntheses of Carbazole Alkaloids 
 
1.  Introduction 
 Carbazole alkaloids are of great interest due to their numerous biological activities.  For 
example, these natural products show antitumor, antibiotic, and antifungal properties, as well as 
having an inhibitory effect on mitosis and activity against malaria.28  Many carbazole alkaloids 
have been isolated from plants belonging to the Rutaceae family.  Most of these compounds have 
a one-carbon substituent in the 3-position and an oxygen functionality in the 1- or 2- position.  
Dimeric and quinoid structures are also known in this group.  We have been interested in a 
number of these natural products, many of which are from plants of the genus Murraya.  These 
plants consist of small trees and shrubs endemic to Southern Asia that have been used for years 
in folk medicine for analgesics and treatment of ailments such as eczema and rheumatism.29 
 Figure 4 shows a few of the carbazole alkaloids that have been of synthetic interest to us.  
Murrayaquinone A, 30 murrayafoline A,30 and dimeric O-demethylmurrayafoline A31 are 
examples of alkaloids isolated from Murraya euchrestifolia Hayata.  Murrayaquinone A is 
known to induce myocardial contraction.  Dimeric O-demethylmurrayafoline A exhibits 
antiplasmodial activity against P. falciparum in vitro.  Murrayanine32 and koenigine-quinone A33 
were both isolated from Murraya koenigii Spreng (Figure 5).34  Murraya koenigii Spreng is 
commonly known as the Indian curry tree.  The leaves which have a distinct odor of anise are 
widely used as a flavoring in Indian curries.  (+)-Aspidospermidine35 has been found in plants of 
the Aspidosperma genus.  While aspidospermidine in itself doesn’t possess any significant 
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biological properties, alkaloids with similar ring structures are known to have antitumor activity.  
Therefore, it can be considered a model for the design of new synthetic approaches toward these 
more functionalized compounds. 
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Figure 5 
 
Murraya koenigii
 Spreng 
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There have been several syntheses of these carbazole alkaloids presented in the literature.  
One common approach to carbazoles is via the Fischer method.  Murrayanine and murrayafoline 
A were prepared in this manner (Scheme 24).32  The Fischer indole synthesis was used to prepare 
carbazolone 1 which was converted to carbazole 75 via dehydrogenation.  Methylation produced 
murrayafoline A, followed by bromination and then hydrolysis with KOH to compound 76.  
Manganese dioxide oxidation of 76 produced the product, murrayanine. 
 
Scheme 24 
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 Murrayafoline A and murrayaquinone A have also been synthesized by a similar 
approach (Scheme 25).36  The key carbazole intermediate 78 along with a small amount of 79 
was also produced by the Fischer method.  Dehydrogenation of tetrahydrocarbazole 78 to the 
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carbazole 80, followed by hydrolysis of the mesyl group gave 81.  Compound 81 could then be 
converted  either to murrayafoline A by methylation, or to murrayaquinone A by oxidation. 
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Koenigine-quinone A also was synthesized via a Fischer indole synthesis-
dehydrogenation-oxidation sequence (Scheme 26).33 
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Another synthetic method to the carbazole, murrayafoline-A, is outlined in Scheme 27.28  
Bringmann et al constructed the carbazole skeleton starting with the indole 85.  Boc-protection 
of the indole nitrogen and olefination with phosphonate 86 using the Horner-Emmons method 
gave 87.  Cyclization with sodium acetate in acetic anhydride followed by methanolysis and then 
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O-methylation gave 88.  Carbazole 88 was converted to murrayafoline A by lithium aluminum 
hydride reduction. 
Moody et al have developed a method toward 1-oxygenated carbazoles starting from 
indole-2-carboxylates (Scheme 28).37  Murrayafoline A was formed from indole-2-carboxylate 
89 by condensation with 4-methylbutyrolactone to give lactone 90, followed by hydrolysis and 
decarboxylation to alcohol 91, and then oxidation to aldehyde 92.  Aldehyde 92 cyclized to 
murrayafoline A upon treatment with boron trifluoride-methanol.  Murrayafoline A was 
converted to murrayaquinone A via a two step demethylation-oxidation sequence. 
 
Scheme 28 
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 Some other synthetic methods to key intermediates of murrayaquinone A include the 
novel Diels-Alder approach by Miki et al38 (Scheme 29), the thermal electrocyclization reactions 
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by Hibino and coworkers39 (Scheme 30), and the annulations of bromo-1,4-benzoquinones and 
enaminones presented by Murphy et al40 (Scheme 31).   
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Åkermark and coworkers41 have also reported the palladium-catalyzed oxidative 
cyclization of 2-arylamino-1,4-quinones to yield several carbazole alkaloids including 
murrayaquinone A (Scheme 32). 
 
Scheme 32 
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Another metal-mediated reaction toward the synthesis of carbazoles was developed by 
Knölker and coworkers42 (Scheme 33).  They use an electrophilic aromatic substitution such as 
that of aniline 103 with a cyclohexadienyltricarbonyliron cation as the key step in the synthesis 
of several carbazoles. 
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Dimeric alkaloids such as dimeric O-demethylmurrayafoline A have been produced via 
the oxidative couplings of carbazole monomers (Scheme 34).43   
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The [ABC]-type subunit in (+)-aspidospermidine has been constructed using a 
copper(I)iodide-promoted arylation originally reported by Suzuki44 in the synthesis by Desmaele 
and d’Angelo (Scheme 35).35  The critical stereochemistry at the CD ring junction was set by the 
asymmetric Michael addition of chiral imine 107 to methyl acrylate.  The ee obtained in this 
reaction was only 86%, but the optical purity of 108 could be efficiently upgraded through 
semicarbazone derivatization and crystallization.  The synthesis of dione 110 was carried out in 
several steps from 108.  The preparation of intermediate 112 was achieved by condensation of 
110 with 2-iodoaniline, followed by cyclization of the enaminone 111.  This synthesis of (+)-
aspidospermidine was completed in a linear sequence of 22 steps from 2-ethylcyclohexanone 
with a 2.7% overall yield. 
 While there are many methods for preparing carbazoles, these methods are not without 
limitations.  Some of the traditional methods lack regioselectivity, and the conditions employed 
are too harsh for some sensitive functional groups.  Another limitation is the availability of 
starting materials for these transformations.  Upon developing our method for the synthesis of 
carbazolones presented in the previous section we decided to apply our approach to the synthesis 
of natural products.  Regioselectivity is not a problem in our method, and a number of functional 
groups are tolerated in these reactions.  The availability of starting materials has also not been a 
difficulty.  The formal total syntheses of several naturally occurring carbazole alkaloids is 
presented. 
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2.  Results and Discussion 
2.1.  Formal Total Synthesis of Murrayaquinone A 
 Carbazolequinones have been efficiently synthesized via the oxidation of 
hydroxycarbazole precursors as previously described.  It is known in the literature38,45 that 3-
methyl-4-hydroxycarbazole can be oxidized to murrayaquinone A using Fremy’s salt 
((KO3S)2NO) in excellent yield (83%).  Therefore, we decided that a potentially useful route to 
the alkaloid would be through carbazolone 116 (Scheme 36).  Dehydrogenation of 116 would 
lead to hydroxycarbazole 117, thus completing the formal total synthesis of murrayaquinone A. 
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 Carbazolone 116 was prepared according to our method previously described, a Stille 
coupling followed by a N-heteroannulation reaction.  2-Iodo-6-methyl-cyclohexen-1-one (114) 
   
 32 
was prepared from cyclohexenone 113 in 71% yield by the iodination method previously 
described in Scheme 14.  The Stille reaction of 114 and stannane 25 in the presence of 
PdCl2(PhCN)2, Ph3As, and CuI in NMP at 80 oC gave 115 in an excellent yield of 87%.  The 
reductive cyclization of 115 also proceeded in an excellent yield (97%) of carbazolone 116.  The 
dehydrogenation reaction of carbazolone 116 using 10% Pd/C in a mixture of diphenyl ether and 
1,2,4-trimethylbenzene at 230 oC gave hydroxycarbazole 117.  It was discovered that the 
addition of a small amount of 1,2,4-trimethylbenzene was critical for the dehydrogenation to 
occur.31  
 Our synthesis of the murrayaquinone A precursor 116 is much more efficient and higher 
yielding than the synthesis by Miki et al.38  Their synthesis took nine steps from dimethyl indole-
2,3-dicarboxylate with an overall yield less than 16%.  Our synthesis was completed in only four 
steps from 6-methyl-2-cyclohexen-1-one with an overall yield of 38%. 
 
2.2.  Formal Synthesis of Four Carbazole Alkaloids 
 While working on our first synthesis of murrayaquinone A, we were also investigating an 
alternative route to this compound via carbazolone 1 (Scheme 37).  We applied the conditions to 
	
-iodo-	
-unsaturated ketones originally developed by Piers and Nagakura46 to prepare 
3-iodo-5-methyl-2-cyclohexen-1-one (119).  The Stille coupling of the cyclohexenone 119 and 
stannane 25 produced 120 in excellent yield (89%).  The reductive cyclization of 120 gave 
carbazolone 1 also in good yield (77%). 
 Carbazolone 1 is an advanced intermediate in reported syntheses of four different 
carbazole alkaloids.  Not only has this intermediate been used in the synthesis of 
murrayaquinone A, but also in the preparation of murrayafoline A, murrayanine, and dimeric O-
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demethylmurrayafoline A.  Carbazolone 1 can be converted to murrayaquinone A through DDQ 
oxidation in 45% yield.47  In the same synthetic sequence murrayafoline A was prepared via the 
dehydrogenation of 1 followed by methylation (see Scheme 24), and then murrayanine was 
produced in two steps from murrayafoline A.32  Dimeric O-demethylmurrayafoline A can also be 
prepared from this intermediate.  1-Hydroxy-3-methylcarbazole,32 the dehydrogenation product 
of carbazolone 1, under oxidative coupling conditions gives the dimeric alkaloid in 87% 
yield.31,48  
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2.3.  Formal Synthesis of Koenigine-quinone A  
 The formal synthesis of koenigine-quinone A was carried out in much the same manner 
as the other syntheses described above.  Stannane 124 was first prepared starting from 
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aminophenol 121 (Scheme 38).  Sandmeyer type reaction of aminophenol 121 produced 
iodophenol 122 which was methylated to 123.  Stannane 124 was prepared from 123 using 
Kosugi’s procedure.17  Stille reaction of 118 and 124 under our usual conditions produced 125 in 
excellent yield (96%) (Scheme 39).  The reductive cyclization also proceeded smoothly giving 
the key intermediate carbazolone 83 in 79%.  Koenigine-quinone A can be synthesized by the 
dehydrogenation reaction of carbazolone 83 followed by oxidation with Fremy’s salt as in the 
synthesis by Saha and Chowdhury.33  Their synthesis gives an overall yield for 83 of 50% in two 
steps from 2-hydroxymethylene-5-methylhexanone and 3-methoxyphenyldiazonium chloride 
while our synthesis produced this intermediate in 76% yield in two steps. 
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2.4.  Formal Synthesis of (+)-Aspidospermidine  
 Desmaele and d’Angelo’s synthesis of (+)-aspidospermidine involves the synthesis of the 
key carbazolone intermediate 112 (Scheme 35).35  The synthesis of this intermediate required 
nine steps from 2-ethylcyclohexanone in 23% yield.  With our new method for making 
carbazolones we thought we could improve upon the synthesis of this intermediate. 
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 We prepared cyclohexenone 109 according to the literature procedure from 2-
ethylcyclohexenone except that we replaced the DDQ oxidation with the palladium-catalyzed 
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dehydrosilylation (Scheme 40).  In our hands, the DDQ method failed to produce 109.  Iodide 
127 was prepared using iodine and pyridine in carbon tetrachloride in 86% yield.  The Stille 
reaction of 127 and 25 with the usual palladium-catalyzed conditions produced 128 in good yield 
(80%).  Cyclization of 128 proceeded smoothly to carbazolone 112 in 76% yield. 
 The synthesis of carbazolone 112 is slightly improved by our method.  In only six steps 
from 2-ethylcyclohexanone we produced this intermediate with an overall yield of 30%. 
 
3.  Conclusions 
 We have successfully applied our novel method of preparing carbazolones to the 
synthesis of several carbazole alkaloids.  The formal total syntheses of murrayaquinone A, 
murrayafoline A, murrayanine, dimeric O-demethylmurrayafoline A, koenigine-quinone A, and 
(+)-aspidospermidine have been achieved using a Stille reaction followed by a palladium-
catalyzed reductive N-heteroannulation as the key steps.  These new syntheses are generally 
more efficient and higher yielding than the previous syntheses of these alkaloids.  
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Part III 
 
Synthesis of Carbazole Derivatives via Palladium-Catalyzed 
Hydrogenation Reactions 
 
 
 
1.  Introduction 
 
 We described a novel route to substituted carbazolones in the previous sections.  
Although the mechanistic details of this reaction are unclear it is doubtful that the reaction 
proceeds through an aniline-type intermediate resulting from reduction of the nitro group.  We 
were curious as to what products might result from the direct reduction of the nitro group in 2-(2-
nitrophenyl)-2-cyclohexen-1-one (32).  
We chose to effect the reduction by a palladium-catalyzed hydrogenation reaction 
(Scheme 41).  Compound 32 in the presence of 10% Pd/C and 1 atm of hydrogen gas in 
methanol at ambient temperature produced 1,2,3,4-tetrahydrocarbazole (129) in 95% yield.  No 
additional products were produced in the reaction. 
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Reduction of compounds related to 32 with TiCl3 have been reported to give 1,2,3,4-
tetrahydrocarbazoles.49  The reduction of 130 with aqueous TiCl3 in acetone gave 1,2,3,4-
tetrahydrocarbazole in 88% yield (Scheme 42).  This latter reaction is inherently regioselective. 
 
Scheme 42 
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 Other common methods to form carbazoles such as the Fischer indole synthesis50 and 
palladium-catalyzed annulations between iodoanilines and ketones51 often suffer from the lack of 
regioselectivity and produce isomers (Scheme 43). 
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To the best of our knowledge there is only one example in the literature of a reductive 
							
-unsaturated ketone moiety.  The reduction of 2-
(2-nitrophenyl)propenal using PtO2 and hydrogen (1 atm) in methanol was reported to produce 
3-methylindole in 40% yield (Scheme 44).52 
 
Scheme 44 
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We envisioned the reductive cyclization of compounds such as 32 using simple 
hydrogenation procedures to be potentially promising for the synthesis of carbazole derivatives.  
We have investigated the scope and limitations of this reaction using several examples. 
 
2.  Results and Discussion  
 We had previously prepared a number of substituted 2-(2-nitrophenyl)-2-cycloalkenones 
for the synthesis of carbazolones as described in Part I and II.  Additional substrates were made 
according to similar procedures.  Compound 142 was synthesized starting from 4-
methylcyclohexanone (138) (Scheme 45).  The silyl enol ether 139 was prepared, followed by 
palladium-catalyzed dehydrosilylation20 to give 4-methyl-2-cyclohexen-1-one (140).  The low 
yield of the dehydrosilylation reaction may be contributed to the volatility of the product.  Iodide 
141 was prepared according to Johnson’s procedure18 using iodine and pyridine in carbon 
tetrachloride in 65% yield.  The Stille reaction of 141 and stannane 25 using PdCl2(PhCN)2, 
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Ph3As, and CuI in NMP gave 142 in good yield (80%).  Compound 144 was prepared similarly 
from the Stille coupling of 2-iodo-3-methylcyclohexenone18 (143) and 25 in 78% yield (Scheme 
46). 
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The results of the reductive cyclizations are summarized in Table 3.  The reductions were 
carried out using 10% Pd/C (~20 mol% Pd) and hydrogen gas (1 atm, balloon) in methanol at 
room temperature.  Most of the reactions were complete in 20 minutes to 2 hours as monitored 
by thin layer chromatography.  Some of the compounds appeared to be acid-sensitive, so for 
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these compounds additional handling precautions were taken such as using base-washed 
glassware, filtering NMR solvents through potassium carbonate prior to use, and using a small 
amount of triethylamine in the chromatography solvents.   
Excellent yields of methyl-substituted carbazoles were obtained from the reductions of 
substrates 115, 33, 142, and 144.  These reactions were very regioselective producing only one 
product per substrate without the formation of other isomers. 
 Investigation of ring-size in the reductive cyclization reaction gave a different result.  
Cycloheptenone 35 gave the expected product 5,6,7,8,9,10-hexahydrocyclohepta[d]indole (147).  
However, cyclopentenone 34 produced the unexpected product 146. 
 Substitution on the benzene ring greatly affected the types of products produced.  Not 
only were tetrahydrocarbazole products produced but tetrahydrocarbazolones and 
hexahydrocarbazoles as well.  There appears to be no correlation between the electron donating 
or withdrawing nature of substituents and the type of products produced.  Two products were 
isolated for the reaction of each substrate 37, 39, and 40. 
 Substrate 70 also gave a surprising result.  The reductive cyclization of this compound 
not only produced the expected carbazolone 5, but 1,2,3,4-tetrahydrocarbazole (129) as well.  In 
order to determine what was happening in this reaction, carbazolone 5 was subjected to the 
hydrogenation conditions (Scheme 47).  Carbazolone 5 did yield some tetrahydrocarbazole 129, 
but 39% of the starting material was still present even after 3 days. 
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Table 3 
O
NO2
N
H
Stille Product Carbazole(s)
129 (95%)
O
NO2
O
NO2
O
NO2
N
H
N
H
N
H
O
NO2
N
H
131 (91%)
135 (92%)
145 (89%)
134 (78%)
32
142
144
33
115
NO2
O
O
NO2
N
H
N
H
146 (83%)
147 (72%)
34
35
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Table 3 continued 
Stille Product Carbazole(s)
O
NO2
O
MeO2C
NO2
N
H
N
H
N
H
N
H
O
CO2Me CO2Me
O
NO2
OMe
O
NO2OH
N
H
N
H
N
H
N
H
MeO MeO
O
148 (17%) 149 (40%)
150 (25%) 151 (39%)
152 (62%) 153 (9%)
129 (22%) 5 (45%)
39
40
37
70
 
General conditions:  10% Pd/C (~20 mol% Pd), hydrogen gas (1 atm, balloon), MeOH, RT.  For more 
exact details see:  Experimental Section. 
 
Scheme 47 
N
H
O
N
H
N
H
O
Pd/C (20 mol % Pd)
H2 (1 atm)
MeOH, 3 days
+
5 (39% recovered) 129 (35%)5
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We also investigated the effect of the amount of palladium in this reaction (Scheme 48).  
Substrate 39 gave only 149 in quantitative yield when the amount of palladium was decreased to 
2 mol%.  This result leads us to believe that the product distribution in other reactions can be 
controlled by adjusting the amount of palladium used.  The reductive cyclizations of other 
substrates have yet to be performed with reduced amounts of catalyst. 
Scheme 48 
O
NO2 N
H
O
Pd/C (2 mol % Pd)
H2 (1 atm)
MeOH, 1h 20min
149 (100%)39
 
Scheme 49 shows the possible intermediates in this reaction.  Reduction of the nitro 
group produces an amine intermediate 154 which can react in either a 1,2- or a 1,4-addition 
fashion with the enone.  The 1,2-addition pathway can give compound 155 which leads to 
tetrahydrocarbazole 129 by direct reduction and isomerization or through intermediate 156 with 
subsequent reduction.  A hexahydrocarbazole product can be formed from many different 
intermediates.  Reduction of intermediates 155 and 156, as well as the tetrahydrocarbazole 
product 129, could all yield a hexahydrocarbazole.  Although the latter pathway is the least likely 
due to the aromaticity of the the tetrahydrocarbazole 129.  Tetrahydrocarbazolone 159 can be 
produced through a 1,4-addition of amine 154 to the enone, followed by tautomerization of enol 
158. 
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Scheme 49 
O
NO2
O
NH2 N N
N
N
N
H
H
H
H
HO
N
O
H
N
H
1,2 addition
1,4-addition
H2
Pd/C
32 154 155
129
156
157
157
158159
 
3.  Conclusions 
We have developed a mild and efficient route to carbazole derivatives through two 
consecutive palladium-catalyzed reactions, a Stille coupling followed by a reductive cyclization 
reaction.  Unsubstituted 2-cyclohexenone and methyl-substituted cyclohexenone starting 
materials give the corresponding 1,2,3,4-tetrahydrocarbazole products exclusively in excellent 
yields.  Substitution on the benzene ring leads to mixtures of 1,2,3,4-tetrahydrocarbazoles, 
1,2,4a,9a-tetrahydro-4(3H)carbazolones, and 1,2,3,4,4a,9a-hexahydrocarbazoles.  The 
cycloheptenone 35 underwent the reductive cyclization to give the expected 5,6,7,8,9,10-
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hexahydrocyclohepta[d]indole, whereas the cyclopentenone 34 resulted in 1,2,3,3a,4,8b-
hexahydrocyclopenta[b]indole.  As of now, there are no explanations for the types and mixtures 
of products in some of these reactions.  However, the method does seem to be excellent for 
selectively producing methyl-substituted carbazoles which can be difficult by other means.  
Further studies of the regiochemistry and mechanism of the reductive cyclization are currently 
underway. 
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Part IV 
Experimental Section 
 
1.  General Procedures 
 
All NMR spectra were determined in CDCl3 at 270 MHz (1H NMR) and 67.5 MHz (13C 
NMR).  The chemical shifts are expresse						4Si (0.00, 1H and 13C) or 
CDCl3 (7.26, 1H and 77.00, 13C) internal standards.  1H-1H coupling constants are reported as 
calculated from spectra; thus, a slight difference between Ja,b and Jb,a is usually obtained.  Results 
of APT (attached proton test) 13C NMR experiments are shown in parentheses, where relative to 
CDCl3, (-) denotes CH3 or CH and (+) denotes CH2 or C. 
Tetrahydrofuran (THF), toluene, and diethyl ether were distilled from sodium 
benzophenone ketyl prior to use.  Pyridine, triethylamine, hexanes, acetonitrile, 
diisopropylamine, and ethyl acetate were distilled from calcium hydride.  Chemicals prepared 
according to literature procedures have been footnoted the first time they are used; all other 
reagents were obtained from commercial sources and used as received.  Silica gel (200-400 
mesh) was used for flash chromatography.  All reactions were performed in oven-dried 
glassware under an argon atmosphere unless otherwise noted.  Solvents were removed on a 
rotary evaporator at water aspirator pressure unless otherwise stated.  IR spectra were recorded 
on neat compounds using NaCl plates unless otherwise noted.  Elemental analyses were 
performed by Atlantic Microlab, Inc., Norcross, GA.  High Resolution Mass Spectra (HRMS) 
were performed at University of California Riverside Mass Spectrometry Center. 
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2.  Experimental Details 
 
2-Iodo-5-methyl-2-cyclohexen-1-one (20).  
To a solution of 5-methyl-2-cyclohexen-1-one19 (47) (502 mg, 4.55 mmol) in 20 mL of 
1:1 CCl4/pyridine cooled to 0 oC was added dropwise a solution of iodine (2.30 g, 9.04 mmol) 
dissolved in 20 mL of 1:1 CCl4/pyridine with stirring.  The reaction mixture was allowed to 
warm to ambient temperature overnight.  The reaction mixture was diluted with ether (100 mL) 
and washed successively with water (40 mL), HCl (5%, aq, 2 x 40 mL), water (40 mL), and 
Na2S2O3 (20%, aq, 40 mL).  The organic phase was dried (MgSO4) and concentrated under 
vacuum.  The crude product was purified by flash chromatography (hexanes/EtOAc, 9:1) to give 
20 (911 mg, 3.86 mmol, 85%) as a light yellow solid:  mp 39-40 oC; IR 2955, 1682, 1590 cm-1; 
1
				 	J = 5.9 Hz, 3H), 2.11-2.53 (m, 4H), 2.69-2.83 (m, 1H), 7.72 (dd, J = 5.9 and 
2.9 Hz, 1H); 13C 		!"#	 -), 30.4 (-), 37.9 (+), 45.0 (+), 103.5 (+), 158.6 (-), 192.5 (+); 
HRMS (EI) calcd for C7H9IO (M+)  235.9698, found 235.9703. 
 
2-Iodo-2-cyclohepten-1-one53 (22).  
To a solution of 2-cyclohepten-1-one (535 mg, 4.86 mmol) in 20 mL of 1:1 CCl4/pyridine 
cooled to 0 oC was added dropwise a solution of iodine (2.71 g, 10.7 mmol) dissolved in 20 mL 
of 1:1 CCl4/pyridine with stirring.  The reaction mixture was allowed to warm to ambient 
temperature overnight.  The reaction mixture was diluted with ether (100 mL) and washed 
successively with water (40 mL), HCl (5%, aq, 2 x 40 mL), water (40 mL), and Na2S2O3 (20%, 
aq, 40 mL).  The organic phase was dried (MgSO4) and concentrated under vacuum.  The crude 
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product was purified by flash chromatography (hexanes/EtOAc, 9:1) to give 22 (786 mg, 3.33 
mmol, 69%) as a light yellow solid. 
 
2-(tri-n-Butylstannyl)-2-cyclohexen-1-one54 (24).  
tert-Butyllithium (34.5 mL of a 1.7 M solution in hexanes, 58.7 mmol) was added 
dropwise to a solution of 6-bromo-1,4-dioxaspiro[4,5]dec-6-ene55 (46) (6.00 g, 27.4 mmol) in 
diethyl ether (480 mL) cooled to –78 oC.  After 30 min, tributyltinchloride (8.2 mL, 30.2 mmol) 
was added slowly, and the reaction mixture stirred another 30 min at –78 oC.  The reaction 
mixture was allowed to warm to room temperature, and HCl (10%, aq, 200mL) was added 
slowly.  The reaction mixture was stirred for 3 h.  After dilution with diethyl ether (500 mL), the 
reaction mixture was washed successively with water (500 mL), NH4OH (10%, aq, 500 mL), and 
water (500 mL).  The organic phase was dried (MgSO4) and concentrated.  The crude product 
was purified by flash chromatography (hexanes/EtOAc, 95:5) to give 24 (8.38 g, 21.8 mmol, 
79%) as a clear, colorless oil. 
 
3-Iodo-2-nitrotoluene56 (29).  
To a mixture of 3-methyl-2-nitroaniline (502 mg, 3.30 mmol), ice, water (4mL), and 
H2SO4 (conc., 0.2 mL) cooled in an ice bath was added a solution of NaNO2 (251 mg, 3.64 
mmol) in water (1 mL) very slowly (~1 drop/min).  After the addition, the reaction mixture was 
stirred 20 min and additional H2SO4 (conc., ~0.07 mL) was added.  The reaction mixture was 
poured slowly into an ice-cold solution of KI (656 mg, 3.95 mL) in water (1 mL).  After a few 
minutes Cu powder (4 mg, 0.06 mmol) was added, and the reaction mixture was warmed slowly 
to 80 oC for about 30 min.  The reaction mixture was allowed to cool, was extracted with CH2Cl2 
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(3 x 50 mL), washed with Na2S2O3 (20%, aq, 50 mL), dried (MgSO4), and concentrated under 
vacuum.  The crude product was purified by flash chromatography (hexanes/EtOAc, 8:2) to give 
29 (764 mg, 2.90 mmol, 88%) as a yellow-orange solid. 
 
4-Bromo-2-iodo-1-nitrobenzene (31).  
To a mixture of 5-bromo-2-nitroaniline57 (54) (198 mg, 0.910 mmol), ice, water (5 mL), 
and H2SO4 (conc., 0.2 mL) cooled to 0 oC was added a solution of NaNO2 (70.2 mg, 1.02 mL) 
very slowly (~1 drop/min).  The reaction mixture was stirred for 1.5 h at room temperature, and 
then was added very slowly to an ice-cold solution of KI (190 mg, 1.14 mmol) in water (1 mL).  
After a few min Cu powder (2 mg, 0.03 mmol) was added, and the reaction mixture was heated 
slowly to 80 oC for 20 min.  The reaction mixture was allowed to cool, was extracted with 
CH2Cl2 (3 x 50 mL), washed with Na2S2O3 (10%, aq, 50 mL), dried (MgSO4), and concentrated 
under vacuum.  The crude product was purified by flash chromatography (hexanes/EtOAc, 9:1) 
to give 31 (182 mg, 0.55 mmol, 61%) as a yellow solid: mp 77-79 oC; IR 1563, 1518, 1335 cm-1; 
1
			 	J = 8.5 and 2.0 Hz, 1H), 7.77 (d, J = 8.5 Hz, 1H), 8.22 (d, J = 2.0 Hz, 1H); 13C 
		$%	 &’	"#% -), 127.7 (+), 132.2 (-), 144.1 (-), 151.7 (+). 
 
2-(2-Nitrophenyl)-2-cyclohexen-1-one23 (32).   
To a solution of 2-iodo-2-cyclohexen-1-one (19)18 (808 mg, 3.64 mmol) and 2-(tri-n-
butylstannyl)-1-nitrobenzene (25)17 (1.80 g, 4.34 mmol) in N-methylpyrrolidinone (NMP) (4 
mL) was added PdCl2(PhCN)2 ( 77.5 mg, 0.20 mmol), Ph3As (117 mg, 0.40 mmol), and CuI 
(77.2 mg, 0.40 mmol).  The reaction mixture was heated at 80 oC for 20 h.  The reaction mixture 
was diluted with EtOAc (100 mL) and washed successively with NH4OH (10%, aq, 3 X 30 mL) 
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and H2O (2 X 30 mL).  The aqueous portions were extracted with EtOAc (50 mL).  The organic 
phases were combined, dried (MgSO4), and concentrated.  The crude product was purified by 
flash chromatography (hexanes/EtOAc, 9:1) to give 32 (603 mg, 2.77 mmol, 76%) as a light 
yellow solid. 
Alternate procedure:  Compound 32 was also prepared repeating the above procedure 
except using 2-(tri-n-butylstannyl)-2-cyclohexenone (24) (931 mg, 2.42 mmol), 1-iodo-2-
nitrobenzene (26) (502 mg, 2.01 mmol), PdCl2(PhCN)2 (38.5 mg, 0.10 mmol), Ph3As (70.1 mg, 
0.22 mmol), CuI (41.9 mg, 0.22 mmol), and NMP (4 mL) to give 32 (309 mg, 1.42 mmol, 71%). 
 
5-Methyl-2-(2-nitrophenyl)-2-cyclohexen-1-one (33).  
The same procedure as described for 32 was repeated except that a mixture of 2-iodo-5-
methyl-2-cyclohexen-1-one (20) (241 mg, 1.02 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene 
(25) (455 mg, 1.10 mmol), PdCl2(PhCN)2 (20.6 mg, 0.05 mmol), Ph3As (31.6 mg, 0.10 mmol), 
CuI (19.1 mg, 0.10 mmol), and NMP (1 mL) gave 33 (175 mg,  0.75 mmol, 74%) as a pale 
yellow solid:  mp 107-109 oC;  IR 1672, 1517, 1340 cm-1;  1			!(	 	J = 8.1 Hz, 3H), 
2.10-2.35 (m, 3H), 2.44-2.59 (m, 2H), 6.90 (dd, J = 5.5 and 2.8 Hz, 1H), 7.16 (dd, J = 7.5 and 
1.6 Hz, 1H), 7.35 (td, J = 6.4 and 1.6 Hz, 1H), 7.49 (td, J = 7.3 and 1.2 Hz, 1H), 7.88 (dd, J = 8.1 
and 1.2, 1H);  13C 		-), 29.9 (-), 34.3 (+), 46.1 (+), 123.9 (-), 128.6 (-), 131.5 (-), 
131.7 (+), 133.2 (-), 138.8 (+), 146.0 (-), 148.4 (+), 196.5 (+);  	
13H13NO3 
(MH+) 232.0974, found 232.0965. 
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2-(2-Nitrophenyl)-2-cyclopenten-1-one (34).  
The same procedure as described for 32 was repeated except that a mixture of 2-iodo-2-
cyclopenten-1-one (21)18 (290 mg, 1.40 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene (25) (643 
mg, 1.56 mmol), PdCl2(PhCN)2 (26.7 mg, 0.07 mmol), Ph3As (43.7 mg, 0.14 mmol), CuI (29.2 
mg, 0.15 mmol), and NMP (2.8 mL) gave 34 (183 mg,  0.90 mmol, 65%) as a pale yellow solid:  
mp 94.5-96.5 oC;  IR 1697, 1518, 1349 cm-1;  1H NMR 	!	")#-2.60 (m, 2H), 2.78-2.83 (m, 2H), 
7.32 (dd, J = 7.5 and 1.6 Hz, 1H), 7.49 (td, J = 7.5 and 1.4 Hz, 1H), 7.61 (td, J = 7.5 and 1.4 Hz, 
1H), 7.69 (t, J = 2.8 Hz, 1H), 8.02 (dd, J = 8.1 and 2.6 Hz, 1H);  13C 		"$	 &’	(%)	 &’	
124.3 (-), 127.1 (+), 129.1 (-), 131.2 (-), 133.0 (-), 143.7 (+), 148.2 (+), 159.0 (-), 205.3 (+);  
Anal. Calcd for C11H9NO3: C, 65.02; H, 4.46.  Found: C, 65.15; H, 4.46. 
 
2-(2-Nitrophenyl)-2-cyclohepten-1-one (35).  
The procedure as described for 32 was repeated except that a mixture of 2-iodo-2-
cyclohepten-1-one (22) (389 mg, 1.65 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene (25) (820 
mg, 1.99 mmol), PdCl2(PhCN)2 (31.9 mg, 0.08 mmol), Ph3As (51.7 mg, 0.16 mmol), CuI (31.2 
mg, 0.16 mmol), and NMP (1.6 mL) gave after purification by flash chromatography 
(benzene/CH2Cl2, 95:5) 35 (259 mg,  1.12 mmol, 68%) as a pale yellow sold:  mp 83-85 oC; IR 
1665, 1517, 1340 cm-1;  1			!-1.99 (m, 4H), 2.53-2.61 (m, 2H), 2.74-2.80 (m, 2H), 
6.74 (t, J = 6.5 Hz, 1H), 7.28 (dd, J = 7.5 and 1.6 Hz, 1H), 7.43 (td, J = 8.1 and 1.6 Hz, 1H), 7.58 
(td, J = 7.5 and 1.6 Hz, 1H) 8.00 (dd, J =8.1 and 1.2 Hz, 1H);  13C 		!"	 &’	")	 &’	
27.8 (+), 42.4 (+), 124.2 (-), 128.5 (-), 132.6 (-), 133.5 (-), 135.1 (+), 142.9 (+), 143.1 (-), 147.2 
(+), 202.5 (+);  HRMS (EI) calcd for C13H13NO3 (M+) 231.0895, found 231.0895. 
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8,9-Dihydro-5H-6-(2-nitrophenyl)-benzocyclohepten-5-one (36).  
The same procedure as described for 32 was repeated except that a mixture of 6-bromo-
8,9-dihydro-5H-benzocyclohepten-5-one (23)21 (250 mg, 1.06 mmol), 1-(tri-n-butylstannyl)-2-
nitrobenzene (25) (496 mg, 1.20 mmol), PdCl2(PhCN)2 (21.5 mg, 0.06 mmol), Ph3As (34.1 mg, 
0.11 mmol), CuI (21.0 mg, 0.11 mmol), and NMP (1 mL) after 40 h gave 36 (183 mg,  0.90 
mmol, 65%) as an orange oil:  IR 3408, 2941, 1665, 1517, 1340 cm-1; 1			"$	 *	J = 5.1 
Hz, 2H), 3.14 (t, J = 5.1 Hz, 2H), 6.81 (t, J = 5.1 Hz, 1H), 7.19-7.70 (m, 7H), 8.07 (dd, J = 8.1 
and 2.9 Hz, 1H); 13+			(#	 &’	(($	 &’	"%(	 -), 127.0 (-), 128.2 (-), 128.6 (-), 129.9 (-), 
132.1 (-), 132.5 (-), 133.4 (-), 136.2 (+), 139.1 (+), 140.9 (+), 141.5 (+), 144.2 (-), 148.1 (+), 
194.2 (+); HRMS (DEI) calcd for C14H15NO4 (MH+) 280.0974, found 280.0964. 
Impurity: 1-nitro-2-(2-nitrophenyl)benzene (43).  Partial 1H			"(	 	J = 8.1 
Hz). Partial 13+			"%	","	(,	(() 
 
2-(4-Methoxy-2-nitrophenyl)-2-cyclohexen-1-one (37).  
The same procedure as described for 32 was repeated except that a mixture of 2-(tri-n-
butylstannyl)-2-cyclohexen-1-one (24) (183 mg, 0.48 mmol), 1-bromo-2-nitro-4-
methoxybenzene (27)58 (103 mg, 0.44 mmol), PdCl2(PhCN)2 (8.2 mg, 0.02 mmol), dppf (24.1 
mg, 0.04 mmol), CuI (8.9 mg, 0.04 mmol), and NMP (1 mL) after 3 days gave 37 (73.4 mg,  
0.30 mmol, 67%) as a yellow-orange solid:  mp 63-65 oC;  IR 1682, 1531, 1357, 1234 cm-1;  1H 
NMR 	!"%	 	J = 5.9 Hz, 2H), 2.52-2.60 (m, 4H), 3.85 (s, 3H), 6.96 (t, J = 4.1, 1H), 7.13-
7.16 (m, 2H), 7.55 (d, J = 3.9 Hz, 1H);  13C 		!""#	 &’	"#"	 &’	((	 &’	))	 -), 109.1 (-
), 119.5 (-), 124.1 (+), 132.4 (-), 139.0 (+), 146.2 (-), 149.0 (+), 159.5 (+), 196.8 (+);  HRMS (EI) 
calcd for C13H13NO3 (M+) 247.0845, found 247.0849. 
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2-(6-Methyl-2-nitrophenyl)-2-cyclohexen-1-one (38).  
The same procedure as described for 32 was repeated except that a mixture of 2-(tri-n-
butylstannyl)-2-cyclohexen-1-one (24) (351 mg, 0.91 mmol), 2-bromo-3-nitrotoluene (28) (177 
mg, 0.82 mmol), PdCl2(PPh3)2 (27.7 mg, 0.04 mmol), and DMF (5 mL) heated at 110 oC for 26 h 
gave 38 (58.2 mg, 0.25  mmol, 31%) as a pale yellow solid:  mp 79-80 oC;  IR 1671, 1520, 1356 
cm-1;  1			!",-2.20 (m, 2H), 2.22 (s, 3H), 2.51 (q, J = 5.7, 2H), 2.57-2.74 (m, 2H), 6.72 
(t, J = 4.2 Hz, 1H), 7.33 (t, J = 7.8 Hz, 1H), 7.46 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 8.1 Hz, 1H);  
13C 		!"	 -), 22.5 (+), 26.0 (+), 38.2 (+), 121.6 (-), 127.9 (-), 131.4 (+), 134.4 (-), 137.2 
(+), 138.3 (+), 146.8 (-), 149.4 (+), 196.8 (+); 	
13H13NO3 (M+) 231.0895, 
found 231.0902. 
 
2-(3-Methyl-2-nitrophenyl)-2-cyclohexen-1-one (39).  
The same procedure as described for 32 was repeated except that a mixture of 2-(tri-n-
butylstannyl)-2-cyclohexen-1-one (24) (385 mg, 1.00 mmol), 3-iodo-2-nitrotoluene (29) (215 
mg, 0.82 mmol), PdCl2(PhCN)2 (15.7 mg, 0.04 mmol), Ph3As (25.3 mg, 0.08 mmol), CuI (16.1 
mg, 0.08 mmol), and NMP (2.5 mL) after 2 days gave 39 (117 mg,  0.51 mmol, 62%) as a pale 
yellow solid:  mp 129-131 oC;  IR 1677, 1523, 1362 cm-1;  1H NMR 	!"	 	J = 6.2 Hz, 
2H), 2.39 (s, 3H), 2.48-2.58 (m, 4H), 6.99 (t, J = 4.3 Hz, 1H), 7.07 (d, J = 7.6 Hz, 1H), 7.26 (d, J 
= 7.8 Hz, 1H), 7.37 (t, J = 7.5 Hz, 1H);  13C 		!)	 -), 22.5 (+), 26.3 (+), 38.3 (+), 128.9  
(-), 130.4 (-), 130.6 (+), 130.7 (+), 131.2 (-), 137.8 (+), 148.6 (-), 150.3 (+), 196.5 (+);  	

(EI) calcd for C13H13NO3 (M+) 231.0895, found 231.0898. 
 
 
   
 55 
2-(6-Carbomethoxy-2-nitrophenyl)-2-cyclohexen-1-one (40).  
The same procedure as described for 32 was repeated except that a mixture of 2-(tri-n-
butylstannyl)-2-cyclohexen-1-one (24) (887 mg, 2.30 mmol), 1-carbomethoxy-2-bromo-3-
nitrobenzene (30)10 (501 mg, 1.92 mmol), PdCl2(PhCN)2 (38.2 mg, 0.10 mmol), Ph3As (59.8 mg, 
0.20 mmol), CuI (39.7 mg, 0.20 mmol), and NMP (4 mL) was degassed by four freeze-pump-
thaw cycles (-78 oC to rt) and was heated at 80 oC for 96 h to give 40 (233 mg,  0.84 mmol, 44%) 
as a yellow-orange solid:  mp 86.5-88.5 oC;  IR 1730, 1681, 1531, 1357, 1294, 1273 cm-1;  1H 
		!")	 	J = 6.3 Hz, 2H), 2.47 (q, J = 5.3 Hz, 2H), 2.63 (t, J = 6.3 Hz, 2H), 6.66 (t, J 
= 4.1 Hz, 1H), 7.53 (t, J = 7.9 Hz, 1H) 7.99 (d, J = 8.1, 1H), 8.12 (d, J = 7.9 Hz, 1H);  13C NMR 
	!"""	 &’	"#	 &’	(	 &’	)"(	 -), 126.9 (-), 128.5 (-), 132.5 (+), 132.7 (+), 133.8 (-), 136.9 
(+), 144.6 (-), 150.3 (+), 165.4 (+), 196.3 (+); 	
14H15NO4 (M+) 275.0794, 
found 275.0804. 
Impurity: Methyl 2-butyl-3-nitrobenzoate (44).  1			,	 	J = 7.3 Hz, 3H), 
1.25-1.42 (m, 4H), 1.64 (pentet, J = 6.9, 2H), 3.63 (s, 3H), 7.68 (t, J = 7.9 Hz, 1H), 8.28-8.33 (m, 
2H).  Partial 13C 		!(%	 -), 17.4 (+), 26.6 (+), 27.6 (+), 52.4 (-), 127.7 (-), 128.8 (-), 134.7 
(-). 
 
2-(5-Bromo-2-nitrophenyl)-2-cyclohexen-1-one (41).   
The same procedure as described for 32 was repeated except that a mixture of 2-(tri-n-
butylstannyl)-2-cyclohexen-1-one (24) (459 mg, 1.19 mmol), 4-bromo-2-iodo-1-nitrobenzene 
(31) (318 mg, 0.97 mmol), PdCl2(PhCN)2 (18.9 mg, 0.05 mmol), Ph3As (30.5 mg, 0.10 mmol), 
CuI (18.2 mg, 0.10 mmol), and NMP (3 mL) after 2 days gave 41 (160 mg, 0.54 mmol, 56%) as 
a yellow-orange solid:  mp 168-169 oC; IR 2948, 1668, 1520, 1557, 1520, 1348 cm-1; 1			
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2.14 (p, J = 5.8 Hz, 2H), 2.52-2.61 (m, 4H), 7.02 (t, J = 3.2 Hz, 1H), 7.41 (d, J = 3.5, 1H), 7.59 
(dd, J = 8.9 and 3.4 Hz, 1H), 7.90 (d, J = 8.7 Hz, 1H); 13+			""%	 &’	"#"	 &’	(	 &’	
125.7 (-), 127.9 (+), 131.7 (-), 133.9 (+), 134.4 (-), 134.5 (+), 138.4 (+), 147.3 (-), 196.1 (+); 
HRMS (DEI) calcd for C12H10BrNO3 (M+) 295.9923, found 295.9915. 
 
[(6,7-Dihydro-5H-benzocyclohepten-9-yl)oxy]trimethylsilane59 (49).  
Butyllithium (10.7 mL of a 1.6 M solution in hexanes, 17.1 mmol) was added dropwise 
to a solution of diisopropylamine (2.85 mL, 20.3 mmol) in THF (42 mL) cooled to –78 oC.  The 
reaction mixture was stirred 5 min, and a solution of 1-benzosuberone (2.49 g, 15.6 mmol) in 
THF (13 mL) was added slowly to the reaction mixture.  The reaction mixture was stirred for 45 
min, and then TMSCl (2.4 mL, 18.9 mmol) and Et3N (4.35 mL, 31.2 mmol) were added slowly.  
The reaction mixture was allowed to warm to ambient temperature over 1 h.  The reaction 
mixture was diluted with diethyl ether (200 mL), washed with water (3 x 50 mL), dried 
(MgSO4), and concentrated.  The crude product was purified by flash chromatography 
(hexanes/Et2O, 9:1) to give 49 (3.43 g, 14.8 mmol, 95%) as a clear, colorless oil. 
 
8,9-Dihydro-5H-benzocyclohepten-5-one60 (50).  
To a solution of 49 (3.04 g, 13.1 mmol) in DMSO (100 mL) was added Pd(OAc)2 (293 
mg, 1.30 mmol).  The reaction flask was flushed with O2 for 5 min.  The reaction mixture was 
stirred at 40 oC under O2 (1 atm, balloon) for 27 h.  The reaction mixture was allowed to cool, 
and then was diluted with 400 mL of EtOAc and washed with water (3 x 100 mL).  The organic 
phase was dried (MgSO4) and concentrated.  The crude product was purified by flash 
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chromatography (hexanes:EtOAc, 9:1) to give 50 (1.92 g, 12.2 mmol, 93%) as a clear, colorless 
oil. 
 
1,2-Dihydrocarbazol-4(3H)-one4 (5).  
2-(2-Nitrophenyl)-2-cyclohexen-1-one (32) (285 mg, 1.31 mmol), Pd(dba)2 (45.3 mg, 
0.08 mmol), dppp (32.5 mg, 0.08 mmol), 1,10-phenanthroline monohydrate (31.2 mg, 0.16 
mmol), and DMF (5 mL) were placed into a pressure tube fitted with a pressure head.  The tube 
was flushed 3 times with CO, and the reaction was heated and stirred at 80 oC under CO (90 psi) 
for 24 h.  The reaction mixture was filtered through Celite and was concentrated under high 
vacuum.  The product was purified via flash chromatography (hexanes/EtOAc, 7:3) to give 5 
(180 mg, 0.97 mmol, 74%) as a white powder. 
Alternate procedure A for compound 5.  Compound 5 was also prepared using the 
above procedure except that a mixture of 2-(2-nitrophenyl)-1,3-cyclohexanedione23 (70) (202 
mg, 0.87 mmol), Pd(dba)2 (29.7 mg, 0.05 mmol), dppp (22.5 mg, 0.05 mmol), 1,10-
phenanthroline monohydrate (23.5 mg, 0.12 mmol), and DMF (5 mL) heated at 100 oC for 90 h 
gave 5 (133 mg, 0.72 mmol, 83%). 
Alternate procedure B for compound 5.  Compound 5 was also prepared using the 
above procedure except that a mixture of 3-methoxy-2-(2-nitrophenyl)-2-cyclohexen-1-one23 
(71) (141 mg, 0.57 mmol), Pd(dba)2 (20.6 mg, 0.04 mmol), dppp (16.3 mg, 0.04 mmol), 1,10-
phenanthroline monohydrate (15.4 mg, 0.08 mmol), and DMF (5 mL) heated at 120 oC for 96 h 
gave 5 (64.5 mg, 0.35 mmol, 61%). 
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2-Methyl-1,2-dihydrocarbazol-4(3H)-one (55).  
The same procedure as described for 5 was repeated except that a mixture of 5-methyl-2-
(2-nitrophenyl)-2-cyclohexenone (33) (98.3 mg, 0.42 mmol), Pd(dba)2 (14.7 mg, 0.03 mmol), 
dppp (10.5 mg, 0.03 mmol), 1,10-phenanthroline monohydrate (10.2 mg, 0.05 mmol), and DMF 
(5 mL) after 36 h gave 55 (75.1 mg, 0.38 mmol, 89%) as a white powder:  mp 260-261 oC; IR 
(Nujol) 2925, 1630, 1583, 1458, 1376 cm-1; 1H NMR (CDCl3 + DMSO-d6’		,	 	J = 6.2 Hz, 
3H), 2.22-2.71 (m, 4H), 2.98-3.11 (m, 1H), 7.11-7.21 (m, 2H), 7.32-7.40 (m, 1H), 8.04-8.12 (m, 
1H), 11.25 (s, 1H); 13C NMR (CDCl3 + DMSO-d6’		"(	 -), 30.4 (+), 30.7 (-), 45.6 (+), 110.5 
(-), 111.1 (+), 119.7 (-), 120.7 (-), 121.6 (-), 123.7 (+), 135.4 (+), 150.8 (+), 192.4 (-). 
 
3,4-Dihydrocyclopent[b]indol-1(2H)-one61 (56).  
The same procedure as described for 5 was repeated except that a mixture of 2-(2-
nitrophenyl)-2-cyclopenten-1-one (34) (125 mg, 0.61 mmol), Pd(dba)2 (21.2 mg, 0.04 mmol), 
dppp (15.7 mg, 0.04 mmol), 1,10-phenanthroline monohydrate (14.8 mg, 0.07 mmol), and DMF 
(5 mL) after 3 days gave 56 (90.4 mg, 0.53 mmol, 86%) as a white powder. 
 
6,7,8,9-Tetrahydrocyclohept[b]indol-10(5H)-one5 (57).  
The same procedure as described for 5 was repeated except that a mixture of 2-(2-
nitrophenyl)-2-cycloheptenone (35) (136 mg, 0.59 mmol), Pd(dba)2 (20.4 mg, 0.04 mmol), dppp 
(14.5 mg, 0.04 mmol), 1,10-phenanthroline monohydrate (14.7 mg, 0.07 mmol), and DMF (5 
mL) after 48 h gave 57 (77.9 mg, 0.39 mmol, 66%) as a white powder. 
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6,7-Dihydrobenzo[4,5]cyclohept-[1,2-b]indol-12(5H)-one8 (58).  
The same procedure as described for 5 was repeated except that a mixture of 36 (31.5 mg, 
0.11 mmol), Pd(dba)2 (5.1 mg, 0.009 mmol), dppp (3.5 mg, 0.009 mmol), 1,10-phenanthroline 
monohydrate (3.4 mg, 0.017 mmol), and DMF (3 mL) after 30 h gave 58 (24.1 mg, 0.098 mmol, 
86%) as a white powder. 
 
7-Methoxy-1,2-dihydrocarbazol-4(3H)-one5 (59).  
The same procedure as described for 5 was repeated except that a mixture of 2-(4-
methoxy-2-nitrophenyl)-2-cyclohexen-1-one (37) (43.5 mg, 0.18 mmol), Pd(dba)2 (6.3 mg, 0.01 
mmol), dppp (4.6 mg, 0.01 mmol), 1,10-phenanthroline monohydrate (4.5 mg, 0.02 mmol), and 
DMF (5 mL) after 22 h gave 59 (33.8 mg, 0.16 mmol, 89%) as a white powder. 
 
5-Methyl-1,2-dihydrocarbazol-4(3H)-one (60).  
The same procedure as described for 5 was repeated except that a mixture of 2-(6-methyl-
2-nitrophenyl)-2-cyclohexen-1-one (38) (117 mg, 0.51 mmol), Pd(dba)2 (17.5 mg, 0.03 mmol), 
dppp (12.7 mg, 0.03 mmol), 1,10-phenanthroline monohydrate (12.4 mg, 0.06 mmol), and DMF 
(5 mL) after 36 h gave 60 (79.5 mg, 0.40 mmol, 79%) as a white powder:  mp 234-235 oC;  IR 
(Nujol) 1711, 1620, 1575 cm-1;  1H NMR (CDCl3 + DMSO-d6’		!"#	 	J = 5.9 Hz, 2H), 
2.50 (t, J = 5.9 Hz, 2H), 2.86 (s, 3H), 2.97 (t, J = 5.9 Hz, 2H), 6.88 (d, J = 7.2, 1H), 7.03 (t, J = 
7.4 Hz, 1H), 7.15 (d, J = 8.2 Hz, 1H), 11.47 (s, 1H);  13C NMR (CDCl3 + DMSO-d6’		!"((	 -), 
23.6 (+), 23.9 (+), 38.9 (+), 109.4 (-), 113.5 (+), 123.2 (-), 123.7 (-), 124.6 (+), 131.7 (+), 137.0 
(+), 153.0 (+), 192.1 (+);  HRMS (EI) calcd for C13H13NO (M+) 199.0997, found 199.0997. 
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8-Methyl-1,2-dihydrocarbazol-4(3H)-one6 (61).  
The same procedure as described for 5 was repeated except that a mixture of 2-(3-methyl-
2-nitrophenyl)-2-cyclohexen-1-one (39) (108 mg, 0.47 mmol), Pd(dba)2 (16.5 mg, 0.03 mmol), 
dppp (11.9 mg, 0.03 mmol), 1,10-phenanthroline monohydrate (11.4 mg, 0.06 mmol), and DMF 
(5 mL) after 144 h gave 61 (69.8 mg, 0.35 mmol, 75%) as a white powder. 
 
Methyl 1,2-dihydrocarbazol-4(3H)-one-5-carboxylate62 (62).  
The same procedure as described for 5 was repeated except that a mixture of 2-(6-
carbomethoxy-2-nitrophenyl)-2-cyclohexen-1-one (40) (158 mg, 0.57 mmol), Pd(dba)2 (19.7 mg, 
0.03 mmol), dppp (14.2 mg, 0.03 mmol), 1,10-phenanthroline monohydrate (13.6 mg, 0.07 
mmol), and DMF (5 mL) after 96 h gave 62 (105 mg, 0.43 mmol, 75%) as a white powder. 
 
6-Bromo-1,2,3,9-tetrahydro-4H-carbazol-4-one63 (63).  
The same procedure as described for 5 was repeated except that a mixture of 2-(5-bromo-
2-nitrophenyl)-2-cyclohexen-1-one (41) (123 mg, 0.42 mmol), Pd(dba)2 (14.3 mg, 0.025 mmol), 
dppp (10.4 mg, 0.025 mmol), 1,10-phenanthroline monohydrate (9.9 mg, 0.050 mmol), and 
DMF (5 mL) after 8 days gave 63 (56.9 mg, 0.22 mmol, 79%) as a white powder. 
 
6,7,8,9-Tetrahydro-5H-pyrido[3,2-b]indol-9-one7 (68).  
A mixture of 2-(tri-n-butylstannyl)-2-cyclohexen-1-one (24) (621 mg, 1.61 mmol), 2-
chloro-3-nitropyridine (66) (201 mg, 1.26 mmol), Pd(dba)2 (22.1 mg, 0.038 mmol), Ph3As (47.1 
mg, 0.15 mmol), and toluene (5 mL)were heated at reflux for 20 h.  The reaction was diluted 
with benzene (100 mL) and washed with NH4OH (10%, aq, 3 X 50 mL) and H2O (2 X 50 mL).  
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The organic phase was dried (MgSO4) and concentrated.  The crude product (67) was used in the 
next procedure without purification.  The same procedure as described for 5 was repeated except 
that the mixture of crude 67, Pd(dba)2 (43.6 mg, 0.075 mmol), dppp (31.2 mg, 0.076 mmol), 
1,10-phenanthroline monohydrate (30.1 mg, 0.152 mmol), and DMF (5 mL) after purification by 
flash chromatography (CHCl3 to CHCl3/MeOH, 9:1) gave 68 (128 mg, 0.685 mmol, 54%) as a 
tan solid. 
 
2-Iodo-6-methyl-2-cyclohexen-1-one (114).  
To a solution of 6-methyl-2-cyclohexen-1-one19 (113) (441 mg, 4.00 mmol) in 20 mL of 
1:1 CCl4/pyridine cooled to 0 oC was added dropwise a solution of iodine (2.09 g, 8.23 mmol) 
dissolved in 20 mL of 1:1 CCl4/pyridine with stirring.  The reaction was allowed to warm to 
ambient temperature overnight.  The reaction mixture was diluted with ether (100 mL) and 
washed successively with water (40 mL), HCl (5%, aq, 2 x 40 mL), water (40 mL), and Na2S2O3 
(20%, aq, 40 mL).  The organic phase was dried (MgSO4) and concentrated under vacuum.  The 
crude product was purified by flash chromatography (hexanes/EtOAc, 9:1) to give 114 (675 mg, 
2.86 mmol, 71%) as a light yellow oil: IR 2929, 1682, 1594, 1454 cm-1; 1			"	 	J = 
6.7 Hz, 3H), 1.75-1.91 (m, 1 H), 2.06-2.18 (m, 1H), 2.35- 2.68 (m, 3H), 7.68-7.73 (m, 1H); 13C 
		)"	 -), 29.0 (+), 29.9 (+), 40.7 (-), 102.8 (+), 158.3 (-), 193.9 (+); HRMS (EI) calcd for 
C7H9IO (M+) 235.9698, found 235.9688. 
 
2-(2-Nitrophenyl)-6-methyl-2-cyclohexen-1-one (115).   
The same procedure as described for 32 was repeated except that a mixture of 2-iodo-6-
methyl-2-cyclohexen-1-one (114) (606 mg, 2.57 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene 
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(25) (1.26 g, 3.07 mmol), PdCl2(PhCN)2 (48.9 mg, 0.13 mmol), Ph3As (78.5 mg, 0.26 mmol), 
CuI (48.7 mg, 0.26 mmol), and NMP (5 mL) after 1.5 days gave 115 (491 mg,  2.12 mmol, 83%) 
as a pale yellow oil:  IR 2931, 1679, 1524, 1349 cm-1; 1			,	 	J = 6.7 Hz, 3H), 1.82-
1.98 (m, 1H), 2.12-2.23 (m, 1H), 2.50-2.67 (m, 3H), 6.96 (td, J = 3.6 and 2.0 Hz, 1 H), 7.26 (dd, 
J = 8.3 and 1.6 Hz, 1H),  7.47 (td, J = 7.5 and 1.6 Hz, 1H), 7.59 (td, J = 7.7 and 1.6 Hz, 1H), 8.02 
(dd, J = 8.1 and 1.4 Hz, 1H); 13+			%$	 -), 25.5 (+), 30.3 (+), 41.5 (-), 123.9 (-), 128.5 (-), 
131.6 (-), 132.1 (+), 133.2 (-), 138.6 (+), 146.0 (-), 148.3 (+), 198.9 (+); HRMS (DEI) calcd for 
C13H13NO3 (MH+) 232.0974, found 232.0968. 
Impurity: 1-nitro-2-(2-nitrophenyl)benzene (43).  1			$(	 	J = 8.1 and 1.6 
Hz), 7.70 (td, J = 7.5 and 1.6 Hz), 8.23 (dd, J = 8.1 and 1.6 Hz).  Partial 13+			"%%	
128.9, 130.8, 134.0. 
 
1,2,3,9-Tetrahydro-3-methyl-4H-carbazol-4-one35 (116).  
The same procedure as described for 5 was repeated except that a mixture of 6-methyl-2-
(2-nitrophenyl)-2-cyclohexenone (115) (187 mg, 0.80 mmol), Pd(dba)2 (31.0 mg, 0.05 mmol), 
dppp (22.2 mg, 0.05 mmol), 1,10-phenanthroline monohydrate (21.4 mg, 0.10 mmol), and DMF 
(5 mL) after 48 h gave 116 (156 mg, 0.78 mmol, 97%) as a white powder. 
 
3-Methyl-9H-carbazol-4-ol64 (117).  
A mixture of 3-methyl-1,2-dihydrocarbazol-4(3H)-one (116) (159 mg, 0.80 mmol), 10% 
Pd/C (108 mg), diphenyl ether (6 mL), and 1,2,4-trimethylbenzene (0.75 mL) was degassed by 
bubbling argon through the mixture for 10 min.  The reaction mixture was heated at 230 oC for 
20 h.  The reaction was filtered through a short column of silica gel using petroleum ether 
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followed by CH2Cl2/formic acid (99.9:0.1) to give 117 (98.9 mg, 0.50 mmol, 63%) as a white 
solid. 
 
3-Iodo-5-methyl-2-cyclohexen-1-one (119).  
To a solution of triphenylphosphine (4.75 g, 18.1 mmol) in acetonitrile (80 mL) was 
added iodine (4.53 g, 17.8 mmol).  The reaction mixture was stirred for 2 h.  Triethylamine (2.6 
mL, 18.7 mmol) was added slowly, followed by 5-methyl-1,3-cyclohexanedione (2.04 g, 16.2 
mmol).  The reaction mixture was stirred for 14 days at ambient temperature.  The solvent was 
evaporated, and the crude product was purified by flash chromatography (hexanes/EtOAc, 95:5) 
to give 119 (3.44 g, 14.6 mmol, 90%) as a light yellow oil:  IR 2956, 1676, 1592 cm-1; 1H NMR 
	$	 	J = 6.5 and 1.8 Hz, 3H), 2.10 (ddd, J = 12.1, 11.7, and 3.6 Hz, 1H), 2.24-2.40 (m, 
1H), 2.46-2.65 (m, 2H), 2.95-3.06 (m, 1H), 6.77-6.82 (m, 1H); 13+			,,	 -), 30.9 (+), 
44.0 (-), 47.6 (-), 125.7 (+), 139.4 (-), 194.3 (+); HRMS (EI) calcd for C7H9IO (M+) 235.9698, 
found 235.9696. 
 
3-(2-Nitrophenyl)-5-methyl-2-cyclohexen-1-one (120).   
The same procedure as described for 32 was repeated except that a mixture of 3-iodo-5-
methyl-2-cyclohexen-1-one (119) (1.00 g, 4.24 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene 
(25) (2.10 g, 5.08 mmol), PdCl2(PhCN)2 (81.3 mg, 0.21 mmol), Ph3As (130 mg, 0.42 mmol), CuI 
(80.8 mg, 0.42 mmol), and NMP (8.4 mL) gave after 48 h 120 (873 mg,  3.78 mmol, 89%) as a 
pale yellow solid:  mp 62-64.5 oC; IR 2956, 1669, 1525, 1346 cm-1; 1			%	 	J = 5.5 
Hz, 3H), 2.13-2.63 (m, 5H), 5.99 (s, 1H), 7.32 (d, J= 7.5 Hz, 1H), 7.56 (td, J = 7.5 and 2.4 Hz, 
1H), 7.69 (td, J = 7.7 and 2.4 Hz, 1H), 8.11 (d, J= 8.1 Hz, 1H);13+			",	 -), 30.7 (-), 38.8 
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(+), 45.4 (+), 124.8 (-), 127.1 (-), 129.4 (-), 129.6 (-), 133.8 (-), 136.4 (+), 146.5 (+), 159.8 (+), 
199.0 (+); HRMS (DEI) calcd for C13H13NO3 (MH+) 232.0974, found 232.0974. 
 
2,3,4,9-Tetrahydro-3-methyl-1H-carbazol-1-one31 (1).  
The same procedure as described for 5 was repeated except that a mixture of 5-methyl-3-
(2-nitrophenyl)-2-cyclohexenone (120) (133 mg, 0.58 mmol), Pd(dba)2 (19.9 mg, 0.03 mmol), 
dppp (14.3 mg, 0.03 mmol), 1,10-phenanthroline monohydrate (13.7 mg, 0.07 mmol), and DMF 
(6 mL) after 72 h gave 1 (88.5 mg, 0.44 mmol, 77%) as a white powder. 
 
4-Iodo-3-nitrophenol65 (122). 
The same procedure as described for 29 was repeated except that 4-amino-3-nitrophenol 
(1.01 g, 6.55 mmol), water (8mL), concentrated H2SO4 (1mL), NaNO2 (506 mg, 7.33 mmol), KI 
(1.30 g, 7.8 mmol), and Cu powder (8.00 mg, 0.13 mmol) gave 122 (1.06 g, 4.00 mmol, 61%) as 
a yellow solid. 
 
1-Iodo-2-nitro-4-methoxybenzene66 (123).   
4-iodo-3-nitrophenol (122) (1.00 g, 3.78 mmol), MeI (2.35 mL, 37.7 mmol), K2CO3 (2.63 
g, 19.0 mmol), and acetone (16 mL) were combined and heated at reflux for 20 h.  The reaction 
mixture was allowed to cool and was filtered.  The filtrate was concentrated to yield 122 (1.05 g, 
3.78 mmol, 100%) as a yellow solid. 
 
 
 
   
 65 
1-(tri-n-Butylstannyl)-2-nitro-4-methoxybenzene (124).   
To a solution of 123 (923 mg, 3.32 mmol) in toluene (6 mL) was added hexabutylditin 
(2.50 mL, 4.95 mmol), PdCl2(PPh3)2 (23.6 mg, 0.03 mmol), and PPh3 (17.6 mg, 0.06 mmol).  
The reaction was heated at 80 oC for 4 days.  The reaction was diluted with benzene (100 mL) 
and washed with NH4OH (10%, aq, 3 X 30 mL) and H2O (2 X 30 mL).  The organic phase was 
dried (MgSO4) and concentrated.  The product was purified by flash chromatography (hexanes) 
to give 124 (1.13 g, 2.55 mmol, 77%) as a yellow oil:  IR 2956, 1528, 1344 cm-1; 1			
0.87 (t, J = 7.3 Hz, 3H), 1.10 (t, J = 7.7Hz, 2H), 1.30 (sextet, J = 4.0 Hz, 2H), 1.42-1.54 (m, 2H), 
3.89 (s, 3H), 7.19 (dd, J = 8.1 and 2.6 Hz, 1H), 7.54 (d, J = 8.1 Hz, 1H), 7.85 (d, J = 4.3 Hz, 1H); 
13
+				 &’	(#	 -), 27.3 (+), 29.0 (+), 55.5 (-), 108.8 (-), 120.6 (-), 130.0 (+), 138.0 (-), 
154.5 (+), 160.5 (+): HRMS (FAB) calcd for C19H33NO3Sn (M-) 443.1482, found 443.1491. 
 
3-(4-Methoxy-2-nitrophenyl)-5-methyl-2-cyclohexen-1-one (125).   
The same procedure as described for 32 was repeated except that a mixture of 3-iodo-5-
methyl-2-cyclohexen-1-one (119) (208 mg, 0.88 mmol), 1-(tri-n-butylstannyl)-4-methoxy-2-
nitrobenzene (124) (445 mg, 1.00 mmol), PdCl2(PhCN)2 (17.2 mg, 0.04 mmol), Ph3As (27.1 mg, 
0.08 mmol), CuI (17.8 mg, 0.09 mmol), and NMP (2 mL) after 2 days gave 125 (222 mg,  0.84 
mmol, 96%) as a yellow solid:  mp 45-47 oC; IR 2953, 1666, 1531, 1350 cm-1; 1				
(d, J = 6.1, 3H), 2.11-2.61 (m, 5H), 3.9 (s, 3H), 5.96 (s, 1H), 7.18-7.21 (m, 2H), 7.58 (d, J = 5.5 
Hz, 1H); 13C 		"	 -), 30.7 (-), 38.9 (+), 45.4 (+), 56.0 (-), 109.81 (-), 119.9 (-), 127.3 (-), 
128.7 (+), 130.7 (-), 147.5 (+), 159.9 (+), 160.03 (+), 199.34 (-); HRMS (DEI) calcd for 
C14H15NO4 (MH+) 262.1080, found 262.1078. 
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2,3,4,9-Tetrahydro-7-methoxy-3-methyl-1H-carbazol-1-one33 (83).  
The same procedure as described for 5 was repeated except that a mixture of 5-methyl-3-
(4-methoxy-2-nitrophenyl)-2-cyclohexenone (125) (73.6 mg, 0.28 mmol), Pd(dba)2 (9.7 mg, 0.02 
mmol), dppp (6.9 mg, 0.02 mmol), 1,10-phenanthroline monohydrate (6.7 mg, 0.04 mmol), and 
DMF (5 mL) gave 83 (57.7 mg, 0.25 mmol, 89%) as a white powder. 
 
Methyl (+)-(S)-1-ethyl-2-oxo-3-cyclohexene-1-propanoate35 (109).   
To a solution of  methyl (+)-(S)-1-ethyl-2-oxocyclohexane-1-propanoate35 (108) (3.25 g, 
15.3 mmol) in DMF (23 mL) was added triethylamine (11.3 mL, 81.1 mmol).  Trimethylsilyl 
chloride (5.93 mL, 46.7 mmol) was added slowly to the reaction mixture.  The reaction mixture 
was heated at 100 oC for 3 days.  The reaction mixture was allowed to cool to RT, and then was 
diluted with hexanes (50 mL) and poured into cold water (50 mL).  The layers were separated, 
and the aqueous portion was extracted with hexanes (3 X 50 mL).  The organic phases were 
combined, dried (MgSO4), and concentrated.  To a portion of the crude silyl enol ether35 (1.94 g, 
6.82 mmol) in DMSO (50 mL) was added Pd(OAc)2 (159 mg, 0.71 mmol).  The flask containing 
the reaction mixture was flushed with oxygen, and was kept under oxygen (1 atm, balloon) while 
being heated at 40 oC for 72 hrs.  Additional Pd(OAc)2 (95.6 mg, 0.43 mmol) was added to the 
reaction mixture, and the reaction was heated at 60 oC for 24 hrs.  The reaction mixture was 
cooled and diluted with ethyl acetate (200 mL).  The reaction mixture was washed with water (3 
X 50 mL), dried (MgSO4), and concentrated.  The product was purified by flash chromatography 
(hexanes/EtOAc, 7:3) to give 109 (820 mg, 3.90 mmol, 57%) as a colorless oil. 
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Methyl (S)-1-ethyl-2-oxo-3-iodo-3-cyclohexenone-1-propanoate (127).  
The same procedure was repeated as described for 22 except that a solution of iodine 
(1.26 g, 4.96 mmol) in CCl4 (5 mL) and pyridine (5 mL) was added to a solution of 109 (508 mg, 
2.42 mmol) in CCl4 (5 mL) and pyridine (5 mL).  The product was purified via flash 
chromatography (hexanes/EtOAc, 8:2) to give 127 (698 mg, 2.08 mmol, 86%) as a light yellow 
oil:  IR 3450, 2944, 1732, 1679 cm-1; 1			(	 	J = 7.5 Hz, 3H), 1.49-1.71 (m, 2H), 
1.80-2.01 (m, 4H), 2.11-2.36 (m, 2H), 2.43-2.50 (m, 2H), 7.64 (t, J = 4.1 Hz, 1H); 13+			
7.9 (-), 26.8 (+), 28.5 (+), 28.5 (+), 30.0 (+), 47.7 (+), 51.4 (-), 103.4 (+), 157.3 (-), 173.5 (+), 
195.3 (+); HRMS (DEI) calcd for C12H17IO3 (MH+) 336.0222, found 336.0210. 
 
Methyl (S)-1-ethyl-2-oxo-3-(2-nitrophenyl)-3-cyclohexenone-1-propanoate (128).   
The same procedure as described for 32 was repeated except that a mixture of 127 (250 
mg, 0.74 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene (25) (369 mg, 0.89 mmol), PdCl2(PhCN)2 
(14.9 mg, 0.04 mmol), Ph3As (23.1 mg, 0.08 mmol), CuI (14.5 mg, 0.08 mmol), and NMP (1.4 
mL) after 40 h gave 128 (196 mg,  0.59 mmol, 80%) as a yellow oil:  IR 3446, 2939, 1736, 1669, 
1526, 1353 cm-1; 1			$	 	J = 7.5 Hz, 3H), 1.52-2.05 (m, 6H), 2.28 (t, J = 7.7 Hz, 2H), 
2.58 (q, J = 4.6 Hz, 2H), 6.94 (t, J = 4.2 Hz, 1H), 7.24 (dd, J = 7.5 and 1.4 Hz, 1H), 7.44 (td, J = 
7.6 and 1.4 Hz, 1H), 7.57 (td, J = 7.5 and 1.4 Hz, 1H), 7.96 (dd, J = 8.1 and 1.2 Hz, 1H); 13C 
		$	 -), 22.6 (+), 26.2 (+), 28.4 (+), 28.5 (+), 30.0 (+), 46.8 (+), 51.4 (-), 123.7 (-), 128.5 
(-), 131.8 (-), 132.1 (+), 132.9 (-), 138.0 (+), 145.4 (-), 148.7 (+), 174.0 (+), 199.3 (+); HRMS 
(DEI) calcd for C12H17IO3 (MH+) 332.1498, found 332.1512. 
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Methyl (-)-(S)-[3-ethyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazol-3-yl]propanoate35 (112).  
The same procedure as described for 5 was repeated except that a mixture of 128 (184 
mg, 0.56 mmol), Pd(dba)2 (19.5 mg, 0.03 mmol), dppp (14.0 mg, 0.03 mmol), 1,10-
phenanthroline monohydrate (13.5 mg, 0.06 mmol), and DMF (5 mL) after chromatography and 
recrystallization (hexanes/EtOAc, 2:1) gave 112 (126 mg, 0.42 mmol, 76%) as a white 
crystalline solid. 
 
1,2,3,4-Tetrahydrocarbazole49a (129).  
Hydrogen gas was bubbled through a mixture of 2-(2-nitrophenyl)-2-cyclohexen-1-one 
(32) (54.3 mg, 0.25 mmol) and 10% Pd/C (50.7 mg) in MeOH (10 mL) for 5 min.  The reaction 
mixture was stirred under H2 (1 atm, balloon) for 2 h.  The reaction mixture was filtered through 
Celite and concentrated.  The crude product was purified by flash chromatography 
(hexanes/EtOAc, 8:2) to yield 129 (41.1 mg, 0.24 mmol, 95%) as a white solid. 
Alternate procedure A for 129 and 5.  The same procedure as described above was 
repeated except that a mixture of 70 (52.9 mg, 0.23 mmol) and 10% Pd/C (51.6 mg) in MeOH 
(10 mL) gave 129 (8.5 mg, 0.049 mmol, 22%) and 5 (18.9 mg, 0.10 mmol, 45%). 
Alternate procedure B for 129.  The same procedure as described above was repeated 
except that a mixture of 5 (18.5 mg, 0.10 mmol) and 10% Pd/C (19.0 mg) in MeOH (5 mL) gave 
129 (6.0 mg, 0.035 mmol, 35%) and recovered 5 (7.3 mg, 0.039 mmol, 39%) after 3 days. 
 
[(4-Methyl-1-cyclohexen-1-yl)oxy]trimethylsilane49a (139).   
Butyllithium (20.0 mL of a 2.5 M solution in hexanes, 50.0 mmol) was added dropwise 
to a solution of diisopropylamine (8.15 mL, 58.2 mmol) in THF (160 mL) cooled to –78 oC 
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under an argon atmosphere.  The reaction mixture was stirred 10 min and a solution of 4-
methylcyclohexanone (5.01 g, 44.6 mmol) in THF (40 mL) was added slowly to the reaction 
mixture.  The reaction mixture was stirred for 30 min, and then TMSCl (6.80 mL, 53.6 mmol) 
and Et3N (12.5 mL, 89.7 mmol) were added slowly.  The reaction mixture was allowed to warm 
to room temperature over 1 h.  The reaction mixture was diluted with diethyl ether (400 mL), 
washed with water (3 x 100 mL), dried (MgSO4), and concentrated.  The crude product was 
purified by flash chromatography (hexanes/EtOAc, 9:1) to give 139 (8.23 g, 44.6 mmol, 100%) 
as a clear, colorless oil. 
 
4-Methyl-2-cyclohexen-1-one19 (140).  
To a solution of 139 (3.14, 17.0mmol) in DMSO (100 mL) was added Pd(OAc)2 (366 
mg, 1.63 mmol).  The reaction flask was flushed with O2 for 5 min.  The reaction mixture was 
stirred at 40 oC under O2 (1 atm, balloon) for 24 h.  The reaction mixture was allowed to cool, 
and then was diluted with 400 mL of EtOAc and washed with water (3 x 100 mL).  The organic 
phase was dried (MgSO4) and concentrated.  The crude product was purified by flash 
chromatography (hexanes:EtOAc, 9:1) to give 140 (676 g, 6.14 mmol, 36%) as a clear, colorless 
oil. 
 
2-Iodo-4-methyl-2-cyclohexen-1-one (141).  
The same procedure was repeated as described for 22 except that a solution of iodine 
(2.97 g, 11.7 mmol) in CCl4 (10 mL) and pyridine (10 mL) was added dropwise to a solution of 
140 (628 mg, 5.70 mmol) in CCl4 (10 mL) and pyridine (10 mL) to yield 141 (873 mg, 3.70 
mmol, 65%) as a yellow oil:  IR 2958, 2870, 1686, 1585, 1454 cm-1; 1			,	 	J = 7.2 
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Hz, 3H), 1.68-1.83 (m, 1H), 2.11-2.23 (m, 1H), 2.48-2.82 (m, 3H), 7.61 (d, J = 2.9 Hz, 1H); 13C 
		,$	 -), 30.6 (+), 35.6 (+), 35.7 (-), 103.0 (+), 164.7 (-), 192.0 (+). 
 
4-Methyl-2-(2-nitrophenyl)-2-cyclohexen-1-one (142).   
The same procedure as described for 32 was repeated except that a mixture of 2-iodo-4-
methyl-2-cyclohexen-1-one (141) (405 g, 1.72 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene (25) 
(854 mg, 2.07 mmol), PdCl2(PhCN)2 (32.9 mg, 0.09 mmol), Ph3As (52.6 mg, 0.17 mmol), CuI 
(32.7 mg, 0.17 mmol), and NMP (4 mL) after 2 days gave 142 (318 mg,  1.38 mmol, 80%) as a 
light yellow oil:  IR 2960, 2871, 1682, 1525, 1352 cm-1; 1H NMR 	"#	 	J = 7.1 Hz, 3H), 
1.74-1.91 (m, 1H), 2.14 (m, 1H), 2.46-2.84 (m, 3H), 6.81 (m, 1H), 7.25 (d, J = 5.9 Hz, 1H), 7.47 
(t, J = 6.3 Hz, 1H), 7.60 (t, J = 7.9 Hz, 1 H), 8.02 (d, J = 8.1 Hz, 1H); 13+			""	 -), 30.5 
(+), 31.6 (-), 37.0 ( +),124.1 (-), 128.7 (-), 131.6 (-), 131.9 (+), 133.2 (-), 138.1 (+), 148.5 (+), 
152.1 (-), 196.4 (+). 
Impurity: 1-Nitro-2-(2-nitrophenyl)benzene (43).  Partial 1			$$,	 	J = 7.9 
Hz), 8.22 (d, J = 8.1 Hz).  Partial 13+			"%#	 -), 129.0 (-), 130.8 (-), 133.4 (-), 134.0. 
 
3-Methyl-2-(2-nitrophenyl)-2-cyclohexen-1-one (144).   
The same procedure as described for 32 was repeated except that a mixture of 2-iodo-3-
methyl-2-cyclohexen-1-one18 (143) (404 mg, 1.71 mmol), 1-(tri-n-butylstannyl)-2-nitrobenzene 
(25) (850 mg, 2.06 mmol), PdCl2(PhCN)2 (32.9 mg, 0.09 mmol), Ph3As (52.4 mg, 0.17 mmol), 
CuI (32.8 mg, 0.17 mmol), and NMP (4 mL) gave 144 (309 mg,  1.33 mmol, 78%) as a light 
yellow solid:  mp 75-77 oC; IR 2943, 2873, 1663, 1622, 1522, 1356 cm-1; 1H NMR 	$	 	
3H), 1.99-2.22 (m, 2H), 2.42-2.64 (m, 4H), 7.16 (dd, J = 7.5 and 1.6 Hz, 1H), 7.47 (td, J = 7.7 
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and 1.6 Hz, 1H), 7.60 (td, J = 7.5 and 1.4 Hz, 1H), 8.08 (dd, J = 8.1 and 1.4Hz, 1H); 13+			
21.8 (+), 22.4 (-), 32.3 (+), 37.5 (+), 124.4 (-), 128.4 (-), 131.7 (+), 132.5 (-), 133.0 (-), 135.1 (+), 
148.8 (+), 156.5 (+), 196.6 (+). 
 
1-Methyl-1,2,3,4-tetrahydrocarbazole67 (131).  
The same procedure as described for 129 was repeated except that a mixture of 6-methyl-
2-(2-nitrophenyl)-2-cyclohexen-1-one (115) (37.0 mg, 0.16 mmol), 10% Pd/C (37.4 mg), and 
MeOH (10 mL) after 2 h and chromatography (hexanes/EtOAc, 95:5) gave 131 (27.2 mg, 0.15 
mmol, 91%) as a white solid. 
 
4-Methyl-1,2,3,4-tetrahydrocarbazole68 (134). 
The same procedure as described for 129 was repeated except that a mixture of 3-methyl-
2-(2-nitrophenyl)-2-cyclohexen-1-one (144) (155 mg, 0.67 mmol), 10% Pd/C (151 mg), and 
MeOH (10 mL) after 30 min and chromatography (hexanes/EtOAc/Et3N, 98:2:1 mL per 500 mL 
of solvent) gave 134 (97.6 mg, 0.52 mmol, 78%) as a white solid. 
 
2-Methyl-1,2,3,4-tetrahydrocarbazole51 (135).  
The same procedure as described for 129 was repeated except that a mixture of 5-methyl-
2-(2-nitrophenyl)-2-cyclohexen-1-one (33) (100 mg,  0.43 mmol), 10% Pd/C ( 100 mg), and 
MeOH (10 mL) after 2 h and chromatography (hexanes/EtOAc/Et3N, 98:2:1 mL/500 mL of 
solvent) gave 135 (73.6 mg, 0.40 mmol, 92%) as a white solid. 
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3-Methyl-1,2,3,4-tetrahydrocarbazole50a (145).  
The same procedure as described for 129 was repeated except that a mixture of 4-methyl-
2-(2-nitrophenyl)-2-cyclohexen-1-one (142) (150 mg, 0.65 mmol), 10% Pd/C (175 mg), and 
MeOH (10 mL) after 30 min and chromatography (hexanes/EtOAc/Et3N, 98:2:1 mL/500 mL of 
solvent) gave 145 (107 mg, 0.58 mmol, 89%) as a white solid. 
 
1,2,3,3a,4,8b-Hexahydrocyclopent[b]indole69 (146).  
The same procedure as described for 129 was repeated except that a mixture of 2-(2-
nitrophenyl)-2-cyclopenten-1-one (34) (117 mg, 0.58 mmol), 10% Pd/C (115 mg), and MeOH 
(10 mL) after 20 min without purification gave 146 (76.1 mg, 0.48 mmol, 83%) as a white solid. 
 
5,6,7,8,9,10-Hexahydrocyclohept[b]indole68 (147).  
The same procedure as described for 129 was repeated except that a mixture of 2-(2-
nitrophenyl)-2-cyclohepten-1-one (35) (65.8 mg, 0.28 mmol), 10% Pd/C (66.0 mg), and MeOH 
(10 mL) after 2.5 h and chromatography (hexanes/EtOAc, 95:5) gave 147 (37.8 mg, 0.20 mmol, 
72%) as a white solid. 
 
8-Methyl-1,2,3,4-tetrahydrocarbazole70 (148) and 8-Methyl-1,2,3,4,4a,9a-
hexahydrocarbazol-1-one (149).  
The same procedure as described for 129 was repeated except that a mixture of 2-(3-
methyl-2-nitrophenyl)-2-cyclohexen-1-one (39) (90.7 mg, 0.39 mmol), 10% Pd/C (90.5 mg), and 
MeOH (10 mL) after 20 min and chromatography (hexanes/EtOAc/Et3N, 98:2:1 mL per 500 mL 
of solvent) gave a mixture of 148 (12.7 mg, 0.07 mmol, 17%) as a white solid and 149 (31.9 mg, 
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0.16 mmol, 40%) as a white solid:  mp 102-104 oC; IR 2934, 1707, 1516, 1370 cm–1;1			
1.73-2.58 (m, 7H, 2.33 (s, 3H), 3.64 (dd, J = 12.4 and 5.3 Hz, 1H), 7.16 (d, J = 7.9 Hz, 1H), 7.21 
(d, J = 7.7 Hz, 1H), 7.39 (t, J = 7.7 Hz, 1H); 13+			$$	 -), 25.4 (+), 27.5 (+), 35.1 (+), 
42.1 (+), 52.4 (-), 127.4 (-), 129.5 (+), 129.9 (-), 130.0 (-), 130.8 (+), 151.4 (-), 207.7 (+). 
Alternate procedure for compound 149.  8-Methyl-1,2,3,4,4a,9a-hexahydrocarbazol-1-
one (149) was also prepared exclusively in the same manner as described above using a mixture 
of 39 (141 mg, 0.61 mmol), 10% Pd/C (13.4 mg), and MeOH (10 mL) after 1 h 20 min to give 
149 (136 mg, 0.67 mmol, 100%). 
 
5-Carbomethoxy-1,2,3,4-tetrahydrocarbazole (150) and 5-Carbomethoxy-1,2,3,4,4a,9a-
hexahydrocarbazol-1-one (151).   
The same procedure as described for 129 was repeated except that a mixture of 2-(6-
carbomethoxy-2-nitrophenyl)-2-cyclohexen-1-one (40) (50.8 mg, 0.18 mmol), 10% Pd/C (54.9 
mg), and MeOH (10 mL) after 2 h and chromatography (hexanes/EtOAc, 95:5) gave a mixture of  
150 (10.7 mg, 0.05 mmol, 25%) and 151 (16.8 mg, 0.07 mmol, 37%) as white solids:  150 1H 
		$$-1.97 (m, 4H), 2.73-2.82 (m, 2H), 2.85-2.93 (m, 2H), 3.94 (s, 3H), 7.11 (td, J = 7.7 
and 1.7 Hz, 1H), 7.43 (dt, J = 8.1 and 1.7 Hz, 1H), 7.64 (dt, J = 7.4 and 1.7 Hz, 1H), 7.93 (s, 
1H); 151 1			)-1.77 (m, 4H), 1.89-2.06(m, 2H), 3.51 (p, J = 6.2 Hz, 1H), 3.80-3.87 
(m, 2H), 3.88 (s, 3H), 6.84 (d, J = 7.9 Hz, 1 H), 7.07 (t, J = 7.9 Hz, 1H), 7.36 (d, J = 7.9 Hz, 1H). 
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7-Methoxy-1,2,3,4-tetrahydrocarbazole71  (152) and 7-Methoxy-1,2,3,4,4a,9a-
hexahydrocarbazol-1-one72 (153)  
The same procedure as described for 129 was repeated except that a mixture of 2-(4-
methoxy-2-nitrophenyl)-2-cyclohexenone (37) (105 mg, 0.42 mmol), 10% Pd/C (104 mg), and 
MeOH (10 mL) after 20 min and chromatography (hexanes/EtOAc/Et3N, 95:5:1 mL per 500 mL 
of solvent) gave an inseparable mixture of 152 (52.5 mg, 0.26 mmol, 62%) and 153 (7.9 mg, 
0.04 mmol, 9%).  Yields were estimated from the 1H NMR spectrum.
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